Gene	Variant_Classification	Alteration	Tumor_allele	Reference_allele	dbSNP_RS	bin	Score_bin	Chromosome	Start_position	End_position	Coverage	Allelic_fraction	Number_of_Probes	Segment_Mean	In_Segment	Pathways	COSMIC_overlapping_mutations	COSMIC_total_alterations_in_gene	UniProt_Region	Rationale	Tumor_Sample_Barcode	Clinical_trials	mutation.assessor
CDKN2A	Copy Number	Deleted	NA	NA	NA	0	Investigate Actionability	9	21971209	22029516	NA	NA	4	-1.6519942592184	FALSE		NA	NA	NA	Biallelic inactivation may predict sensitivity to CDK4/6 inhibitors.	MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN2A&recr=Open">Click here</a>	
CDKN2B	Copy Number	Deleted	NA	NA	NA	0	Investigate Actionability	9	21971209	22029516	NA	NA	4	-1.6519942592184	TRUE		NA	NA	NA	Biallelic inactivation may predict sensitivity to CDK4/6 inhibitors.	MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN2B&recr=Open">Click here</a>	
NRAS	Missense_Mutation	p.Q61K	G	G	rs121913254	0	Actionable	1	115256530	115256530	485	0.529896907216495	NA	NA	NA		p.Q61K(595)|p.Q61E(9)|p.Q61L(3)|p.Q61R(2)|p.G60>?(1)	3085		Mutations predict resistance to RAF- inhibitors. Mutations may be sensitive to MEK inhibitors.	MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRAS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,115256530,G,G&fts=all">p.Q61K</a>
NF1	Missense_Mutation	p.L499P	T	T		1	Investigate Actionability	17	29541572	29541572	163	0.47239263803681	NA	NA	NA		p.0?(8)|p.?(5)|p.L499P(1)	599		Biallelic inactivation may predict sensitivity to PI3K pathway inhibitors (PI3K/AKT/MTOR).  Biallelic inactivation mapy predict resistance to RAF and MEK inhibitors.	MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,29541572,T,T&fts=all">p.L499P</a>
TP53	Splice_Site		C	C		1	Investigate Actionability	17	7577498	7577498	57	0.631578947368421	NA	NA	NA		p.?(29)|p.0?(8)|p.E258fs*71(1)	24185		Biallelic inactivation or mutation may be prognostic in some tumor types.  They may also predict sensitivity to some cell cycle inhibitors and p53 specific gene therapies or immunotherapies. May signal the presence of a germline mutation.	MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP53&recr=Open">Click here</a>	
ABL1	Missense_Mutation	p.R1013Q	G	G		2	High Priority	9	133760715	133760715	138	0.0289855072463768	NA	NA	NA			1195	F-actin-binding.|Pro-rich.	Translocations predict sensitivity to tyrosine kinase inhibitors such as imatinib, dasatinib, and nilotinib.  Secondary mutations can cause resistance to these agents.	MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,133760715,G,G&fts=all">p.R1013Q</a>
MTOR	Missense_Mutation	p.L2022F	G	G		2	High Priority	1	11187833	11187833	416	0.201923076923077	NA	NA	NA			149	Sufficient for interaction with the FKBP1A/rapamycin complex. {ECO:0000250}.	Activating mutations may predict sensitivity to MTOR inhibitors. Secondary mutations may predict resistance to MTOR inhibitors	MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTOR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,11187833,G,G&fts=all">p.L2022F</a>
SUFU	Missense_Mutation	p.P187L	C	C		3	Investigate Actionability	10	104352444	104352444	261	0.218390804597701	NA	NA	NA		p.P187L(1)	24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUFU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,104352444,C,C&fts=all">p.P187L</a>
ARID2	Missense_Mutation	p.S297F	C	C		4	Cancer Gene Census	12	46230641	46230641	260	0.353846153846154	NA	NA	NA			116			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,46230641,C,C&fts=all">p.S297F</a>
ARID2	Nonsense_Mutation	p.K555*	A	A		4	Cancer Gene Census	12	46242701	46242701	157	0.248407643312102	NA	NA	NA			116			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,46242701,A,A&fts=all">p.K555*</a>
BRIP1	Frame_Shift_Ins	p.N1087fs	-	-		4	Cancer Gene Census	17	59761146	59761147	314	0.273885350318471	NA	NA	NA			55			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRIP1&recr=Open">Click here</a>	
CHN1	Missense_Mutation	p.G147E	C	C		4	Cancer Gene Census	2	175742677	175742677	254	0.5	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,175742677,C,C&fts=all">p.G147E</a>
ERCC5	Missense_Mutation	p.P53T	C	C		4	Cancer Gene Census	13	103504536	103504536	288	0.263888888888889	NA	NA	NA			51	N-domain.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,103504536,C,C&fts=all">p.P53T</a>
ERCC5	Missense_Mutation	p.P53L	C	C		4	Cancer Gene Census	13	103504537	103504537	287	0.257839721254355	NA	NA	NA			51	N-domain.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,103504537,C,C&fts=all">p.P53L</a>
FANCA	Missense_Mutation	p.R714Q	C	C		4	Cancer Gene Census	16	89838096	89838096	149	0.302013422818792	NA	NA	NA			47			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FANCA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,89838096,C,C&fts=all">p.R714Q</a>
IL21R	Missense_Mutation	p.L242F	C	C		4	Cancer Gene Census	16	27456536	27456536	90	0.255555555555556	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL21R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,27456536,C,C&fts=all">p.L242F</a>
JAZF1	Missense_Mutation	p.S234L	G	G		4	Cancer Gene Census	7	27872450	27872450	372	0.0134408602150538	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAZF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,27872450,G,G&fts=all">p.S234L</a>
KLK2	Missense_Mutation	p.E161K	G	G	rs371591640	4	Cancer Gene Census	19	51380002	51380002	62	0.274193548387097	NA	NA	NA			11	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,51380002,G,G&fts=all">p.E161K</a>
RAD51B	Missense_Mutation	p.R231K	G	G		4	Cancer Gene Census	14	68353857	68353857	245	0.151020408163265	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD51B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,68353857,G,G&fts=all">p.R231K</a>
WRN	Missense_Mutation	p.D1172N	G	G		4	Cancer Gene Census	8	31004934	31004934	191	0.371727748691099	NA	NA	NA			60	HRDC. {ECO:0000255|PROSITE- ProRule:PRU00328}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,31004934,G,G&fts=all">p.D1172N</a>
COL4A1	Missense_Mutation	p.S402Y	G	G		4.07142857142857	Cancer Pathway Linked to: MTOR; NRAS; ABL1; SUFU; TP53; CDKN2A; CDKN2B	13	110850894	110850894	177	0.446327683615819	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		105	Triple-helical region.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,110850894,G,G&fts=all">p.S402Y</a>
COL4A4	Missense_Mutation	p.M868I	C	C		4.07142857142857	Cancer Pathway Linked to: MTOR; NRAS; ABL1; SUFU; TP53; CDKN2A; CDKN2B	2	227920773	227920773	77	0.155844155844156	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		98	Triple-helical region.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,227920773,C,C&fts=all">p.M868I</a>
STK36	Missense_Mutation	p.S484F	C	C		4.07142857142857	Cancer Pathway Linked to: MTOR; NRAS; ABL1; SUFU; TP53; CDKN2A; CDKN2B	2	219553490	219553490	233	0.145922746781116	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		52			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219553490,C,C&fts=all">p.S484F</a>
WNT9A	Missense_Mutation	p.R186Q	C	C		4.07142857142857	Cancer Pathway Linked to: MTOR; NRAS; ABL1; SUFU; TP53; CDKN2A; CDKN2B	1	228111897	228111897	248	0.032258064516129	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		19			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WNT9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228111897,C,C&fts=all">p.R186Q</a>
VEGFC	Missense_Mutation	p.R349K	C	C		4.16666666666667	Cancer Pathway Linked to: NRAS; TP53; CDKN2A	4	177608440	177608440	547	0.451553930530165	NA	NA	NA	 KEGG_BLADDER_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		41	4 X 16 AA repeats of C-X(10)-C-X-C- X(1,3)-C.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VEGFC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,177608440,C,C&fts=all">p.R349K</a>
CTNNA3	Missense_Mutation	p.G50R	C	C		4.25	Cancer Pathway Linked to: NRAS; TP53	10	69366759	69366759	237	0.232067510548523	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		95			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,69366759,C,C&fts=all">p.G50R</a>
APP	Splice_Site		C	C		4.5	Cancer Pathway Linked to: TP53	21	27347542	27347542	185	0.243243243243243	NA	NA	NA	 KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APP&recr=Open">Click here</a>	
APP	Splice_Site		T	T		4.5	Cancer Pathway Linked to: TP53	21	27347543	27347543	181	0.243093922651934	NA	NA	NA	 KEGG_COLORECTAL_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APP&recr=Open">Click here</a>	
RS1	Missense_Mutation	p.P203S	G	G		5	Cancer Pathway	X	18660192	18660192	98	0.744897959183674	NA	NA	NA	 BIOCARTA_IGF1R_PATHWAY  | 		15	F5/8 type C. {ECO:0000255|PROSITE- ProRule:PRU00081}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,18660192,G,G&fts=all">p.P203S</a>
ULBP1	Missense_Mutation	p.P207S	C	C		5	Cancer Pathway	6	150290490	150290490	270	0.351851851851852	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		10	MHC class I alpha-2 like.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ULBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,150290490,C,C&fts=all">p.P207S</a>
ADRBK2	Missense_Mutation	p.R295Q	G	G	rs200351696	6.75	Cancer Module	22	26083561	26083561	371	0.0161725067385445	NA	NA	NA			32	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADRBK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,26083561,G,G&fts=all">p.R295Q</a>
RIPK2	Missense_Mutation	p.R264H	G	G		6.75	Cancer Module	8	90784994	90784994	257	0.0194552529182879	NA	NA	NA			10	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,90784994,G,G&fts=all">p.R264H</a>
ABCB11	Missense_Mutation	p.T550I	G	G		7	Cancer Module	2	169826715	169826715	50	0.12	NA	NA	NA			57	ABC transporter 1. {ECO:0000255|PROSITE- ProRule:PRU00434}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCB11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,169826715,G,G&fts=all">p.T550I</a>
ABCC5	Missense_Mutation	p.S113P	A	A		7	Cancer Module	3	183706466	183706466	136	0.419117647058824	NA	NA	NA			62			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,183706466,A,A&fts=all">p.S113P</a>
ADAM2	Missense_Mutation	p.V490I	C	C		7	Cancer Module	8	39606909	39606909	285	0.301754385964912	NA	NA	NA			53	Cys-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39606909,C,C&fts=all">p.V490I</a>
ADAM2	Missense_Mutation	p.E159K	C	C		7	Cancer Module	8	39678559	39678559	291	0.285223367697594	NA	NA	NA			53			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39678559,C,C&fts=all">p.E159K</a>
ADCY3	Missense_Mutation	p.S156F	G	G		7	Cancer Module	2	25059880	25059880	67	0.507462686567164	NA	NA	NA			44			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,25059880,G,G&fts=all">p.S156F</a>
AFP	Missense_Mutation	p.E321K	G	G		7	Cancer Module	4	74313296	74313296	216	0.537037037037037	NA	NA	NA			22	Albumin 2. {ECO:0000255|PROSITE- ProRule:PRU00769}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74313296,G,G&fts=all">p.E321K</a>
AHDC1	Missense_Mutation	p.V980I	C	C		7	Cancer Module	1	27875689	27875689	328	0.0213414634146341	NA	NA	NA			42			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,27875689,C,C&fts=all">p.V980I</a>
AIFM2	Missense_Mutation	p.P186L	G	G		7	Cancer Module	10	71877627	71877627	91	0.340659340659341	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIFM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,71877627,G,G&fts=all">p.P186L</a>
ALDH4A1	Missense_Mutation	p.R171W	G	G	rs367696082	7	Cancer Module	1	19209865	19209865	116	0.0431034482758621	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH4A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,19209865,G,G&fts=all">p.R171W</a>
ALPK2	Missense_Mutation	p.P546S	G	G		7	Cancer Module	18	56246372	56246372	252	0.444444444444444	NA	NA	NA			84			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALPK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,56246372,G,G&fts=all">p.P546S</a>
ANK1	Splice_Site	p.G1369R	C	C	rs540967954	7	Cancer Module	8	41546107	41546107	58	0.293103448275862	NA	NA	NA			122			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	
ANK3	Missense_Mutation	p.P2384S	G	G		7	Cancer Module	10	61833489	61833489	155	0.238709677419355	NA	NA	NA			196			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61833489,G,G&fts=all">p.P2384S</a>
ANK3	Missense_Mutation	p.E674K	C	C		7	Cancer Module	10	61946538	61946538	109	0.339449541284404	NA	NA	NA			196			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61946538,C,C&fts=all">p.E674K</a>
ANXA1	Missense_Mutation	p.D93Y	G	G		7	Cancer Module	9	75775185	75775185	307	0.355048859934853	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,75775185,G,G&fts=all">p.D93Y</a>
APCS	Missense_Mutation	p.G171E	G	G		7	Cancer Module	1	159558338	159558338	170	0.0823529411764706	NA	NA	NA			20	Pentaxin.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APCS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,159558338,G,G&fts=all">p.G171E</a>
APOB	Missense_Mutation	p.A3517T	C	C	rs573670976	7	Cancer Module	2	21229191	21229191	237	0.455696202531646	NA	NA	NA			305			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,21229191,C,C&fts=all">p.A3517T</a>
APOB	Missense_Mutation	p.S2646F	G	G		7	Cancer Module	2	21231803	21231803	295	0.511864406779661	NA	NA	NA			305			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,21231803,G,G&fts=all">p.S2646F</a>
APOLD1	Missense_Mutation	p.A125T	G	G		7	Cancer Module	12	12940212	12940212	130	0.0307692307692308	NA	NA	NA			5			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOLD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,12940212,G,G&fts=all">p.A125T</a>
AQP3	Missense_Mutation	p.F88C	A	A		7	Cancer Module	9	33443429	33443429	39	0.358974358974359	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AQP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,33443429,A,A&fts=all">p.F88C</a>
ARHGAP22	Missense_Mutation	p.D103N	C	C		7	Cancer Module	10	49763541	49763541	154	0.194805194805195	NA	NA	NA			18	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,49763541,C,C&fts=all">p.D103N</a>
ATAD2	Missense_Mutation	p.G80R	C	C		7	Cancer Module	8	124358919	124358919	311	0.212218649517685	NA	NA	NA			48			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATAD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,124358919,C,C&fts=all">p.G80R</a>
ATL1	Nonsense_Mutation	p.R217*	C	C		7	Cancer Module	14	51079995	51079995	287	0.0174216027874564	NA	NA	NA			18	GB1/RHD3-type G.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,51079995,C,C&fts=all">p.R217*</a>
ATP10B	Missense_Mutation	p.R272Q	C	C		7	Cancer Module	5	160071198	160071198	143	0.461538461538462	NA	NA	NA			75			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP10B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,160071198,C,C&fts=all">p.R272Q</a>
ATRN	Missense_Mutation	p.L1317F	C	C		7	Cancer Module	20	3619481	3619481	107	0.373831775700935	NA	NA	NA			59			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,3619481,C,C&fts=all">p.L1317F</a>
ATXN7	Missense_Mutation	p.P247L	C	C		7	Cancer Module	3	63965831	63965831	136	0.205882352941176	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATXN7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,63965831,C,C&fts=all">p.P247L</a>
AUTS2	Missense_Mutation	p.H147R	A	A		7	Cancer Module	7	69364402	69364402	215	0.46046511627907	NA	NA	NA			50			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AUTS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,69364402,A,A&fts=all">p.H147R</a>
BFSP2	Missense_Mutation	p.Q251H	G	G		7	Cancer Module	3	133169170	133169170	116	0.21551724137931	NA	NA	NA			13	Rod.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BFSP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,133169170,G,G&fts=all">p.Q251H</a>
BMP6	Missense_Mutation	p.P230L	C	C		7	Cancer Module	6	7845397	7845397	194	0.288659793814433	NA	NA	NA			23			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,7845397,C,C&fts=all">p.P230L</a>
C8A	Missense_Mutation	p.E363K	G	G		7	Cancer Module	1	57351831	57351831	230	0.526086956521739	NA	NA	NA			43	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C8A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,57351831,G,G&fts=all">p.E363K</a>
CASR	Missense_Mutation	p.P611L	C	C		7	Cancer Module	3	122002633	122002633	146	0.5	NA	NA	NA			84			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,122002633,C,C&fts=all">p.P611L</a>
CC2D2A	Missense_Mutation	p.T491R	C	C		7	Cancer Module	4	15534821	15534821	98	0.357142857142857	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CC2D2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,15534821,C,C&fts=all">p.T491R</a>
CCL11	Missense_Mutation	p.D71N	G	G		7	Cancer Module	17	32614626	32614626	111	0.0810810810810811	NA	NA	NA		p.D71N(1)	3			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCL11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,32614626,G,G&fts=all">p.D71N</a>
CD1C	Missense_Mutation	p.D140N	G	G		7	Cancer Module	1	158261963	158261963	391	0.332480818414322	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158261963,G,G&fts=all">p.D140N</a>
CD86	Missense_Mutation	p.S194F	C	C		7	Cancer Module	3	121825243	121825243	435	0.4	NA	NA	NA			23	Ig-like C2-type.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD86&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121825243,C,C&fts=all">p.S194F</a>
CDC14A	Missense_Mutation	p.L141F	C	C		7	Cancer Module	1	100905519	100905519	287	0.139372822299652	NA	NA	NA			31	A.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC14A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,100905519,C,C&fts=all">p.L141F</a>
CDH23	Missense_Mutation	p.E1650K	G	G		7	Cancer Module	10	73537524	73537524	69	0.260869565217391	NA	NA	NA			133	Cadherin 16. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,73537524,G,G&fts=all">p.E1650K</a>
CDT1	Missense_Mutation	p.A347S	G	G		7	Cancer Module	16	88872999	88872999	50	0.24	NA	NA	NA			7			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,88872999,G,G&fts=all">p.A347S</a>
CEP135	Missense_Mutation	p.E546D	A	A		7	Cancer Module	4	56847404	56847404	343	0.268221574344023	NA	NA	NA			50			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP135&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,56847404,A,A&fts=all">p.E546D</a>
CHAF1A	Missense_Mutation	p.V29I	G	G		7	Cancer Module	19	4405941	4405941	324	0.234567901234568	NA	NA	NA			27	Binds to CBX1 chromo shadow domain.|Binds to PCNA.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHAF1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4405941,G,G&fts=all">p.V29I</a>
CHD7	Missense_Mutation	p.L2498P	T	T		7	Cancer Module	8	61769332	61769332	258	0.395348837209302	NA	NA	NA			123			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,61769332,T,T&fts=all">p.L2498P</a>
CKAP4	Missense_Mutation	p.P387L	G	G	rs572869064	7	Cancer Module	12	106633451	106633451	132	0.28030303030303	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CKAP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,106633451,G,G&fts=all">p.P387L</a>
CNGB1	Missense_Mutation	p.V372M	C	C		7	Cancer Module	16	57983264	57983264	86	0.337209302325581	NA	NA	NA			54			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,57983264,C,C&fts=all">p.V372M</a>
CNN2	Missense_Mutation	p.T252M	C	C		7	Cancer Module	19	1037724	1037724	359	0.0167130919220056	NA	NA	NA			10			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,1037724,C,C&fts=all">p.T252M</a>
COLEC11	Missense_Mutation	p.E108K	G	G		7	Cancer Module	2	3687915	3687915	84	0.154761904761905	NA	NA	NA			22	Collagen-like.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COLEC11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,3687915,G,G&fts=all">p.E108K</a>
CRLS1	Missense_Mutation	p.R117I	G	G		7	Cancer Module	20	5990464	5990464	230	0.239130434782609	NA	NA	NA			4			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRLS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,5990464,G,G&fts=all">p.R117I</a>
CTAGE1	Missense_Mutation	p.H6Y	G	G		7	Cancer Module	18	19997759	19997759	91	0.516483516483517	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTAGE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,19997759,G,G&fts=all">p.H6Y</a>
CYP4A11	Missense_Mutation	p.P438L	G	G	rs373468480	7	Cancer Module	1	47398484	47398484	627	0.15311004784689	NA	NA	NA			36			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4A11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,47398484,G,G&fts=all">p.P438L</a>
CYP4F12	Missense_Mutation	p.A230V	C	C		7	Cancer Module	19	15794344	15794344	150	0.446666666666667	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,15794344,C,C&fts=all">p.A230V</a>
DDR1	Splice_Site	p.L82L	T	T		7	Cancer Module	6	30856980	30856980	498	0.323293172690763	NA	NA	NA			29	F5/8 type C. {ECO:0000255|PROSITE- ProRule:PRU00081}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDR1&recr=Open">Click here</a>	
DNAH7	Missense_Mutation	p.P3395L	G	G		7	Cancer Module	2	196664189	196664189	165	0.478787878787879	NA	NA	NA			205			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196664189,G,G&fts=all">p.P3395L</a>
DNAH7	Missense_Mutation	p.P3395S	G	G		7	Cancer Module	2	196664190	196664190	164	0.481707317073171	NA	NA	NA			205			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196664190,G,G&fts=all">p.P3395S</a>
DNMBP	Splice_Site	p.SVLTG1053fs	CACACATGCGGACTCCTGGAGCCAGTTAGGACAGA	CACACATGCGGACTCCTGGAGCCAGTTAGGACAGA	rs562802539|rs368593342|rs544642099|rs141530740	7	Cancer Module	10	101648696	101648730	40	0.1	NA	NA	NA			61	BAR. {ECO:0000255|PROSITE- ProRule:PRU00361}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNMBP&recr=Open">Click here</a>	
DNMBP	Missense_Mutation	p.P448S	G	G		7	Cancer Module	10	101715889	101715889	248	0.395161290322581	NA	NA	NA			61			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNMBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,101715889,G,G&fts=all">p.P448S</a>
DONSON	Missense_Mutation	p.R220C	G	G	rs202191803	7	Cancer Module	21	34956981	34956981	155	0.032258064516129	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DONSON&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,34956981,G,G&fts=all">p.R220C</a>
DPYS	Splice_Site	p.G265R	C	C		7	Cancer Module	8	105456476	105456476	162	0.296296296296296	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYS&recr=Open">Click here</a>	
DSCAM	Missense_Mutation	p.E1836K	C	C		7	Cancer Module	21	41414478	41414478	209	0.263157894736842	NA	NA	NA			142			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,41414478,C,C&fts=all">p.E1836K</a>
DSG1	Missense_Mutation	p.E605K	G	G		7	Cancer Module	18	28923538	28923538	94	0.372340425531915	NA	NA	NA			76			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28923538,G,G&fts=all">p.E605K</a>
DUSP27	Missense_Mutation	p.E482K	G	G	rs200300656	7	Cancer Module	1	167095812	167095812	72	0.527777777777778	NA	NA	NA			89			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,167095812,G,G&fts=all">p.E482K</a>
EIF1	Missense_Mutation	p.G19S	G	G		7	Cancer Module	17	39846053	39846053	240	0.354166666666667	NA	NA	NA			5			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39846053,G,G&fts=all">p.G19S</a>
EIF1	Missense_Mutation	p.G19D	G	G		7	Cancer Module	17	39846054	39846054	240	0.3625	NA	NA	NA			5			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39846054,G,G&fts=all">p.G19D</a>
ELF3	Missense_Mutation	p.A310V	C	C		7	Cancer Module	1	201983080	201983080	40	0.6	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELF3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,201983080,C,C&fts=all">p.A310V</a>
ENPEP	Missense_Mutation	p.E815D	A	A		7	Cancer Module	4	111470986	111470986	192	0.21875	NA	NA	NA			54			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,111470986,A,A&fts=all">p.E815D</a>
FANCM	Missense_Mutation	p.R1619H	G	G	rs377502779	7	Cancer Module	14	45658159	45658159	126	0.0317460317460317	NA	NA	NA			85			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FANCM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,45658159,G,G&fts=all">p.R1619H</a>
FBN1	Missense_Mutation	p.R2311C	G	G		7	Cancer Module	15	48720609	48720609	194	0.0257731958762887	NA	NA	NA			139	EGF-like 40; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,48720609,G,G&fts=all">p.R2311C</a>
FBN3	Missense_Mutation	p.R781Q	C	C	rs367947634	7	Cancer Module	19	8191671	8191671	95	0.242105263157895	NA	NA	NA			132	EGF-like 10; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8191671,C,C&fts=all">p.R781Q</a>
FCGBP	Missense_Mutation	p.D1173N	C	C		7	Cancer Module	19	40412111	40412111	124	0.193548387096774	NA	NA	NA			165	Cys-rich.|TIL 2.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40412111,C,C&fts=all">p.D1173N</a>
FCN1	Missense_Mutation	p.R10W	G	G	rs531095841	7	Cancer Module	9	137809690	137809690	72	0.444444444444444	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,137809690,G,G&fts=all">p.R10W</a>
FCN2	Splice_Site		G	G		7	Cancer Module	9	137775202	137775202	90	0.511111111111111	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCN2&recr=Open">Click here</a>	
FKBP5	Missense_Mutation	p.P47S	G	G		7	Cancer Module	6	35604902	35604902	151	0.251655629139073	NA	NA	NA			17	PPIase FKBP-type 1. {ECO:0000255|PROSITE- ProRule:PRU00277}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FKBP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,35604902,G,G&fts=all">p.P47S</a>
FLNC	Missense_Mutation	p.D2389N	G	G		7	Cancer Module	7	128495282	128495282	358	0.304469273743017	NA	NA	NA			128			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLNC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,128495282,G,G&fts=all">p.D2389N</a>
FLRT2	Missense_Mutation	p.L54V	T	T		7	Cancer Module	14	86088018	86088018	233	0.0386266094420601	NA	NA	NA			73	LRRNT.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLRT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,86088018,T,T&fts=all">p.L54V</a>
GIPC2	Missense_Mutation	p.L182V	T	T		7	Cancer Module	1	78560753	78560753	350	0.528571428571429	NA	NA	NA			20	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIPC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,78560753,T,T&fts=all">p.L182V</a>
GLCCI1	Missense_Mutation	p.S293L	C	C		7	Cancer Module	7	8099790	8099790	257	0.45136186770428	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLCCI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,8099790,C,C&fts=all">p.S293L</a>
GLO1	Missense_Mutation	p.T182I	G	G		7	Cancer Module	6	38645081	38645081	188	0.25531914893617	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38645081,G,G&fts=all">p.T182I</a>
GOLT1B	Missense_Mutation	p.R61K	G	G		7	Cancer Module	12	21665306	21665306	314	0.331210191082803	NA	NA	NA			5	Phe-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLT1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,21665306,G,G&fts=all">p.R61K</a>
GRIK2	Missense_Mutation	p.P407S	C	C		7	Cancer Module	6	102266260	102266260	83	0.325301204819277	NA	NA	NA			83			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,102266260,C,C&fts=all">p.P407S</a>
GRIK2	Missense_Mutation	p.I825M	T	T		7	Cancer Module	6	102503368	102503368	233	0.334763948497854	NA	NA	NA			83			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,102503368,T,T&fts=all">p.I825M</a>
HAND2	Missense_Mutation	p.E108K	C	C		7	Cancer Module	4	174450119	174450119	207	0.27536231884058	NA	NA	NA			13	bHLH. {ECO:0000255|PROSITE- ProRule:PRU00981}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAND2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,174450119,C,C&fts=all">p.E108K</a>
HEATR5A	Missense_Mutation	p.F1311L	A	A		7	Cancer Module	14	31790741	31790741	80	0.525	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEATR5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,31790741,A,A&fts=all">p.F1311L</a>
HEPH	Missense_Mutation	p.E749K	G	G		7	Cancer Module	X	65476088	65476088	85	0.529411764705882	NA	NA	NA			89	Plastocyanin-like 5.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEPH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,65476088,G,G&fts=all">p.E749K</a>
HIVEP1	Missense_Mutation	p.R1949K	G	G		7	Cancer Module	6	12125874	12125874	180	0.394444444444444	NA	NA	NA			90			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIVEP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,12125874,G,G&fts=all">p.R1949K</a>
HIVEP2	Missense_Mutation	p.S210F	G	G		7	Cancer Module	6	143095247	143095247	223	0.354260089686099	NA	NA	NA			100			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIVEP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,143095247,G,G&fts=all">p.S210F</a>
HLA-DQA1	Missense_Mutation	p.S245L	C	C		7	Cancer Module	6	32610507	32610507	92	0.619565217391304	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLA-DQA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32610507,C,C&fts=all">p.S245L</a>
HSD17B3	Splice_Site	p.I92I	G	G	rs143401138	7	Cancer Module	9	99017151	99017151	65	0.661538461538462	NA	NA	NA			13			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD17B3&recr=Open">Click here</a>	
HSPA8	Missense_Mutation	p.V369A	A	A		7	Cancer Module	11	122930195	122930195	335	0.229850746268657	NA	NA	NA			36	Interaction with BAG1.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,122930195,A,A&fts=all">p.V369A</a>
IGF2BP3	Splice_Site		C	C		7	Cancer Module	7	23358756	23358756	241	0.24896265560166	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGF2BP3&recr=Open">Click here</a>	
IGFBP2	Missense_Mutation	p.D101N	G	G		7	Cancer Module	2	217526641	217526641	62	0.516129032258065	NA	NA	NA			5	IGFBP N-terminal. {ECO:0000255|PROSITE- ProRule:PRU00653}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGFBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,217526641,G,G&fts=all">p.D101N</a>
IL1R1	Missense_Mutation	p.F406C	T	T		7	Cancer Module	2	102792019	102792019	518	0.167953667953668	NA	NA	NA			19	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102792019,T,T&fts=all">p.F406C</a>
ISLR2	Nonsense_Mutation	p.Q273*	C	C		7	Cancer Module	15	74425912	74425912	83	0.180722891566265	NA	NA	NA			36	Ig-like.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ISLR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,74425912,C,C&fts=all">p.Q273*</a>
ITGA10	Missense_Mutation	p.S360F	C	C		7	Cancer Module	1	145532760	145532760	208	0.644230769230769	NA	NA	NA			59			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,145532760,C,C&fts=all">p.S360F</a>
ITGB3	Missense_Mutation	p.G61R	G	G		7	Cancer Module	17	45360770	45360770	239	0.338912133891213	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,45360770,G,G&fts=all">p.G61R</a>
ITPR2	Missense_Mutation	p.E1287K	C	C		7	Cancer Module	12	26752221	26752221	306	0.0163398692810458	NA	NA	NA			125			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,26752221,C,C&fts=all">p.E1287K</a>
KCNAB1	Missense_Mutation	p.E52K	G	G		7	Cancer Module	3	155838554	155838554	99	0.313131313131313	NA	NA	NA			28			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNAB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,155838554,G,G&fts=all">p.E52K</a>
KCNN4	Missense_Mutation	p.G38E	C	C		7	Cancer Module	19	44284901	44284901	288	0.444444444444444	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNN4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44284901,C,C&fts=all">p.G38E</a>
KDELR3	Missense_Mutation	p.R169W	C	C	rs142169266	7	Cancer Module	22	38877370	38877370	211	0.023696682464455	NA	NA	NA			13			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDELR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38877370,C,C&fts=all">p.R169W</a>
KEAP1	Missense_Mutation	p.R470C	G	G		7	Cancer Module	19	10600447	10600447	96	0.177083333333333	NA	NA	NA		p.R470C(3)|p.R470S(1)	92			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KEAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10600447,G,G&fts=all">p.R470C</a>
KEL	Missense_Mutation	p.S273F	G	G		7	Cancer Module	7	142651377	142651377	221	0.438914027149321	NA	NA	NA			60			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KEL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,142651377,G,G&fts=all">p.S273F</a>
KIAA0430	Missense_Mutation	p.D1101N	C	C		7	Cancer Module	16	15703538	15703538	175	0.291428571428571	NA	NA	NA			40	HTH OST-type 3. {ECO:0000255|PROSITE- ProRule:PRU00975}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0430&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,15703538,C,C&fts=all">p.D1101N</a>
KIAA0753	Missense_Mutation	p.P829T	G	G		7	Cancer Module	17	6493906	6493906	128	0.5390625	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0753&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,6493906,G,G&fts=all">p.P829T</a>
KIAA0922	Missense_Mutation	p.P957S	C	C		7	Cancer Module	4	154525033	154525033	117	0.222222222222222	NA	NA	NA			63			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0922&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,154525033,C,C&fts=all">p.P957S</a>
KIF14	Missense_Mutation	p.S70F	G	G		7	Cancer Module	1	200587643	200587643	327	0.574923547400612	NA	NA	NA			61	Required for PRC1-binding.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,200587643,G,G&fts=all">p.S70F</a>
KNG1	Missense_Mutation	p.E77K	G	G	rs377271899	7	Cancer Module	3	186437927	186437927	141	0.390070921985816	NA	NA	NA		p.E77*(2)	21	Cystatin kininogen-type 1. {ECO:0000255|PROSITE-ProRule:PRU00979}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KNG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,186437927,G,G&fts=all">p.E77K</a>
LAP3	Missense_Mutation	p.R25W	C	C		7	Cancer Module	4	17579161	17579161	24	0.583333333333333	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,17579161,C,C&fts=all">p.R25W</a>
LRP1B	Missense_Mutation	p.D3384N	C	C		7	Cancer Module	2	141202156	141202156	112	0.419642857142857	NA	NA	NA			606	LDL-receptor class A 22. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141202156,C,C&fts=all">p.D3384N</a>
LRP1B	Missense_Mutation	p.G3383V	C	C		7	Cancer Module	2	141202158	141202158	110	0.427272727272727	NA	NA	NA			606	LDL-receptor class A 22. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141202158,C,C&fts=all">p.G3383V</a>
MACF1	Missense_Mutation	p.Y5239H	T	T		7	Cancer Module	1	39854214	39854214	155	0.219354838709677	NA	NA	NA			203			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MACF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,39854214,T,T&fts=all">p.Y5239H</a>
MAEA	Missense_Mutation	p.V376M	G	G		7	Cancer Module	4	1332895	1332895	188	0.0265957446808511	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAEA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,1332895,G,G&fts=all">p.V376M</a>
MAP4K4	Nonsense_Mutation	p.Q883*	C	C		7	Cancer Module	2	102493560	102493560	131	0.526717557251908	NA	NA	NA			41	Mediates interaction with RAP2A.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP4K4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102493560,C,C&fts=all">p.Q883*</a>
MAP7	Missense_Mutation	p.R573C	G	G		7	Cancer Module	6	136681921	136681921	564	0.343971631205674	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,136681921,G,G&fts=all">p.R573C</a>
MBD4	Missense_Mutation	p.R432C	G	G		7	Cancer Module	3	129152810	129152810	245	0.0204081632653061	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,129152810,G,G&fts=all">p.R432C</a>
MBD4	Missense_Mutation	p.S321L	G	G		7	Cancer Module	3	129155525	129155525	294	0.22108843537415	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,129155525,G,G&fts=all">p.S321L</a>
MED12L	Splice_Site	p.G453G	G	G		7	Cancer Module	3	150883634	150883634	497	0.211267605633803	NA	NA	NA			128			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED12L&recr=Open">Click here</a>	
MED23	Nonsense_Mutation	p.R1167*	G	G		7	Cancer Module	6	131912640	131912640	124	0.032258064516129	NA	NA	NA			44			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,131912640,G,G&fts=all">p.R1167*</a>
MGAM	Missense_Mutation	p.P62S	C	C		7	Cancer Module	7	141708362	141708362	74	0.297297297297297	NA	NA	NA			13	Ser/Thr-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,141708362,C,C&fts=all">p.P62S</a>
MPPED1	Missense_Mutation	p.P20S	C	C		7	Cancer Module	22	43821049	43821049	44	0.25	NA	NA	NA			13			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPPED1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,43821049,C,C&fts=all">p.P20S</a>
MTBP	Missense_Mutation	p.L266F	C	C		7	Cancer Module	8	121471503	121471503	204	0.230392156862745	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121471503,C,C&fts=all">p.L266F</a>
MUC13	Missense_Mutation	p.R351K	C	C		7	Cancer Module	3	124632438	124632438	228	0.263157894736842	NA	NA	NA			18	EGF-like 2. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,124632438,C,C&fts=all">p.R351K</a>
MUC16	Missense_Mutation	p.M8912I	C	C		7	Cancer Module	19	9060710	9060710	349	0.501432664756447	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9060710,C,C&fts=all">p.M8912I</a>
MUC16	Missense_Mutation	p.S2842L	G	G		7	Cancer Module	19	9083290	9083290	46	0.326086956521739	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9083290,G,G&fts=all">p.S2842L</a>
MUC4	Missense_Mutation	p.G205R	C	C		7	Cancer Module	3	195497164	195497164	71	0.267605633802817	NA	NA	NA			51			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,195497164,C,C&fts=all">p.G205R</a>
MYCBP2	Missense_Mutation	p.F1199L	A	A		7	Cancer Module	13	77779612	77779612	137	0.306569343065693	NA	NA	NA			118			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,77779612,A,A&fts=all">p.F1199L</a>
MYO3A	Missense_Mutation	p.G312R	G	G		7	Cancer Module	10	26315442	26315442	50	0.32	NA	NA	NA			146			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,26315442,G,G&fts=all">p.G312R</a>
MYO5B	Missense_Mutation	p.R836H	C	C	rs373039798	7	Cancer Module	18	47431106	47431106	138	0.108695652173913	NA	NA	NA			87	Arg-rich.|IQ 3. {ECO:0000255|PROSITE- ProRule:PRU00116}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,47431106,C,C&fts=all">p.R836H</a>
MYOM2	Missense_Mutation	p.F956L	T	T		7	Cancer Module	8	2054165	2054165	122	0.311475409836066	NA	NA	NA			104	Ig-like C2-type 3.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2054165,T,T&fts=all">p.F956L</a>
NAGPA	Missense_Mutation	p.T298I	G	G		7	Cancer Module	16	5078908	5078908	287	0.306620209059233	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAGPA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,5078908,G,G&fts=all">p.T298I</a>
NEK11	Splice_Site		G	G		7	Cancer Module	3	130799433	130799433	104	0.355769230769231	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK11&recr=Open">Click here</a>	
NFIX	Missense_Mutation	p.A183V	C	C		7	Cancer Module	19	13136346	13136346	116	0.387931034482759	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFIX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,13136346,C,C&fts=all">p.A183V</a>
NID2	Missense_Mutation	p.A610S	C	C		7	Cancer Module	14	52507567	52507567	126	0.0793650793650794	NA	NA	NA			87	Nidogen G2 beta-barrel. {ECO:0000255|PROSITE-ProRule:PRU00348}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,52507567,C,C&fts=all">p.A610S</a>
NLRP3	Missense_Mutation	p.D662N	G	G		7	Cancer Module	1	247588729	247588729	207	0.579710144927536	NA	NA	NA			142			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247588729,G,G&fts=all">p.D662N</a>
NOS1	Missense_Mutation	p.H1274Y	G	G		7	Cancer Module	12	117662929	117662929	154	0.246753246753247	NA	NA	NA			117			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117662929,G,G&fts=all">p.H1274Y</a>
NOSIP	Missense_Mutation	p.R67C	G	G		7	Cancer Module	19	50062213	50062213	572	0.0122377622377622	NA	NA	NA			11	U-box-like.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOSIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50062213,G,G&fts=all">p.R67C</a>
NPC1	Missense_Mutation	p.P256S	G	G		7	Cancer Module	18	21140310	21140310	78	0.0897435897435897	NA	NA	NA			38	Poly-Pro.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,21140310,G,G&fts=all">p.P256S</a>
NRG2	Missense_Mutation	p.D608N	C	C		7	Cancer Module	5	139228239	139228239	18	0.222222222222222	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,139228239,C,C&fts=all">p.D608N</a>
NRK	Missense_Mutation	p.G332E	G	G		7	Cancer Module	X	105150556	105150556	13	0.615384615384615	NA	NA	NA			76			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,105150556,G,G&fts=all">p.G332E</a>
OLFM4	Missense_Mutation	p.S56F	C	C		7	Cancer Module	13	53603138	53603138	158	0.246835443037975	NA	NA	NA			39	Ser-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,53603138,C,C&fts=all">p.S56F</a>
OTX2	Missense_Mutation	p.N269T	T	T		7	Cancer Module	14	57268517	57268517	165	0.0303030303030303	NA	NA	NA			19			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,57268517,T,T&fts=all">p.N269T</a>
PAX2	Splice_Site	p.G341G	G	G		7	Cancer Module	10	102586767	102586767	55	0.290909090909091	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAX2&recr=Open">Click here</a>	
PBX4	Missense_Mutation	p.S255F	G	G		7	Cancer Module	19	19680262	19680262	310	0.480645161290323	NA	NA	NA			9			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PBX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,19680262,G,G&fts=all">p.S255F</a>
PCLO	Missense_Mutation	p.R4461Q	C	C		7	Cancer Module	7	82538248	82538248	201	0.238805970149254	NA	NA	NA			259			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82538248,C,C&fts=all">p.R4461Q</a>
PCLO	Missense_Mutation	p.E2849K	C	C		7	Cancer Module	7	82581724	82581724	87	0.413793103448276	NA	NA	NA			259			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82581724,C,C&fts=all">p.E2849K</a>
PCSK2	Splice_Site		G	G		7	Cancer Module	20	17338971	17338971	54	0.37037037037037	NA	NA	NA			53			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK2&recr=Open">Click here</a>	
PCSK2	Splice_Site	p.V95I	G	G		7	Cancer Module	20	17338972	17338972	58	0.344827586206897	NA	NA	NA			53			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK2&recr=Open">Click here</a>	
PCSK5	Missense_Mutation	p.G1289E	G	G		7	Cancer Module	9	78936400	78936400	289	0.273356401384083	NA	NA	NA			55	CRM (Cys-rich motif).		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,78936400,G,G&fts=all">p.G1289E</a>
PHF20	Missense_Mutation	p.E662G	A	A		7	Cancer Module	20	34505565	34505565	60	0.266666666666667	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHF20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,34505565,A,A&fts=all">p.E662G</a>
PKD1L1	Missense_Mutation	p.E299K	C	C		7	Cancer Module	7	47968966	47968966	322	0.503105590062112	NA	NA	NA			142			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,47968966,C,C&fts=all">p.E299K</a>
PKIB	Missense_Mutation	p.S53F	C	C		7	Cancer Module	6	123039097	123039097	112	0.232142857142857	NA	NA	NA			4			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKIB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,123039097,C,C&fts=all">p.S53F</a>
PLEKHA4	Missense_Mutation	p.G173D	C	C		7	Cancer Module	19	49362900	49362900	177	0.661016949152542	NA	NA	NA			30	Pro-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49362900,C,C&fts=all">p.G173D</a>
PLEKHA4	Missense_Mutation	p.G173S	C	C		7	Cancer Module	19	49362901	49362901	174	0.660919540229885	NA	NA	NA			30	Pro-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49362901,C,C&fts=all">p.G173S</a>
PPFIA2	Missense_Mutation	p.S594F	G	G		7	Cancer Module	12	81747111	81747111	90	0.3	NA	NA	NA			85			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPFIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,81747111,G,G&fts=all">p.S594F</a>
PPFIA2	Missense_Mutation	p.S295F	G	G		7	Cancer Module	12	81777902	81777902	73	0.383561643835616	NA	NA	NA			85	Glu-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPFIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,81777902,G,G&fts=all">p.S295F</a>
PPOX	Splice_Site	p.G330E	G	G		7	Cancer Module	1	161140200	161140200	178	0.308988764044944	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPOX&recr=Open">Click here</a>	
PPP1R3A	Missense_Mutation	p.G840E	C	C		7	Cancer Module	7	113518628	113518628	385	0.52987012987013	NA	NA	NA			121			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,113518628,C,C&fts=all">p.G840E</a>
PTAFR	Missense_Mutation	p.V234M	C	C		7	Cancer Module	1	28476833	28476833	90	0.166666666666667	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTAFR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,28476833,C,C&fts=all">p.V234M</a>
PTCRA	Missense_Mutation	p.G68A	G	G		7	Cancer Module	6	42890909	42890909	126	0.0634920634920635	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCRA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,42890909,G,G&fts=all">p.G68A</a>
PTPRO	Missense_Mutation	p.N966T	A	A		7	Cancer Module	12	15731854	15731854	142	0.309859154929577	NA	NA	NA			74	Tyrosine-protein phosphatase. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,15731854,A,A&fts=all">p.N966T</a>
PTPRT	Nonsense_Mutation	p.Q625*	G	G		7	Cancer Module	20	40944629	40944629	86	0.255813953488372	NA	NA	NA			176	Fibronectin type-III 4. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,40944629,G,G&fts=all">p.Q625*</a>
RAB4A	Nonsense_Mutation	p.R84*	C	C		7	Cancer Module	1	229431617	229431617	266	0.0225563909774436	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB4A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,229431617,C,C&fts=all">p.R84*</a>
RAI1	Missense_Mutation	p.P376S	C	C		7	Cancer Module	17	17697388	17697388	129	0.410852713178295	NA	NA	NA			48			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,17697388,C,C&fts=all">p.P376S</a>
RAI1	Missense_Mutation	p.P1112L	C	C		7	Cancer Module	17	17699597	17699597	22	0.409090909090909	NA	NA	NA			48			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAI1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,17699597,C,C&fts=all">p.P1112L</a>
RELN	Missense_Mutation	p.G3296R	C	C		7	Cancer Module	7	103126741	103126741	237	0.472573839662447	NA	NA	NA			227			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103126741,C,C&fts=all">p.G3296R</a>
RELN	Missense_Mutation	p.L2213S	A	A		7	Cancer Module	7	103183211	103183211	284	0.53169014084507	NA	NA	NA			227			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103183211,A,A&fts=all">p.L2213S</a>
RERE	Missense_Mutation	p.P643S	G	G		7	Cancer Module	1	8421912	8421912	169	0.50887573964497	NA	NA	NA			49			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RERE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,8421912,G,G&fts=all">p.P643S</a>
RGS1	Missense_Mutation	p.E25K	G	G		7	Cancer Module	1	192544995	192544995	138	0.0869565217391304	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,192544995,G,G&fts=all">p.E25K</a>
RGS1	Missense_Mutation	p.E110K	G	G		7	Cancer Module	1	192547399	192547399	340	0.464705882352941	NA	NA	NA			22	RGS. {ECO:0000255|PROSITE- ProRule:PRU00171}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,192547399,G,G&fts=all">p.E110K</a>
RPAIN	Missense_Mutation	p.R37W	C	C	rs7222862	7	Cancer Module	17	5324643	5324643	90	0.0444444444444444	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPAIN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,5324643,C,C&fts=all">p.R37W</a>
RPL4	Missense_Mutation	p.R248C	G	G		7	Cancer Module	15	66792408	66792408	156	0.294871794871795	NA	NA	NA		p.R342C(1)	17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,66792408,G,G&fts=all">p.R248C</a>
RREB1	Missense_Mutation	p.A1115V	C	C		7	Cancer Module	6	7231676	7231676	72	0.319444444444444	NA	NA	NA			58			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RREB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,7231676,C,C&fts=all">p.A1115V</a>
RYR1	Missense_Mutation	p.E2381D	A	A		7	Cancer Module	19	38990390	38990390	38	0.210526315789474	NA	NA	NA			285	6 X approximate repeats.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38990390,A,A&fts=all">p.E2381D</a>
RYR2	Missense_Mutation	p.P866S	C	C		7	Cancer Module	1	237666788	237666788	123	0.0569105691056911	NA	NA	NA			586	4 X approximate repeats.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237666788,C,C&fts=all">p.P866S</a>
RYR2	Missense_Mutation	p.A1927V	C	C		7	Cancer Module	1	237780650	237780650	84	0.30952380952381	NA	NA	NA			586	4 X approximate repeats.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237780650,C,C&fts=all">p.A1927V</a>
RYR3	Missense_Mutation	p.S3395L	C	C		7	Cancer Module	15	34102837	34102837	72	0.333333333333333	NA	NA	NA			311			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,34102837,C,C&fts=all">p.S3395L</a>
SCN9A	Missense_Mutation	p.P229S	G	G		7	Cancer Module	2	167160751	167160751	124	0.0887096774193548	NA	NA	NA			108			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,167160751,G,G&fts=all">p.P229S</a>
SERPINC1	Splice_Site		C	C		7	Cancer Module	1	173880030	173880030	289	0.57439446366782	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINC1&recr=Open">Click here</a>	
SETBP1	Missense_Mutation	p.S259F	C	C		7	Cancer Module	18	42530081	42530081	156	0.0897435897435897	NA	NA	NA			104			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,42530081,C,C&fts=all">p.S259F</a>
SIRPB1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	20	1552685	1559342	NA	NA	2	-1.10005101381033	FALSE		NA	NA	NA		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIRPB1&recr=Open">Click here</a>	
SLC26A8	Missense_Mutation	p.G838E	C	C		7	Cancer Module	6	35912077	35912077	125	0.248	NA	NA	NA			46			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC26A8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,35912077,C,C&fts=all">p.G838E</a>
SLC9A6	Missense_Mutation	p.P649L	C	C		7	Cancer Module	X	135126723	135126723	86	0.63953488372093	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9A6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,135126723,C,C&fts=all">p.P649L</a>
SNAP91	Missense_Mutation	p.S608F	G	G		7	Cancer Module	6	84302688	84302688	12	0.5	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNAP91&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,84302688,G,G&fts=all">p.S608F</a>
SNTG1	Missense_Mutation	p.Q380K	C	C		7	Cancer Module	8	51617259	51617259	79	0.139240506329114	NA	NA	NA			66	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNTG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,51617259,C,C&fts=all">p.Q380K</a>
SNTG2	Missense_Mutation	p.S221F	C	C		7	Cancer Module	2	1204859	1204859	226	0.150442477876106	NA	NA	NA			52			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNTG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,1204859,C,C&fts=all">p.S221F</a>
SPAG1	Missense_Mutation	p.P771S	C	C		7	Cancer Module	8	101252661	101252661	188	0.228723404255319	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,101252661,C,C&fts=all">p.P771S</a>
SPDEF	Missense_Mutation	p.E275K	C	C		7	Cancer Module	6	34507033	34507033	248	0.290322580645161	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPDEF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,34507033,C,C&fts=all">p.E275K</a>
SPOCK3	Missense_Mutation	p.S159F	G	G		7	Cancer Module	4	167833778	167833778	132	0.25	NA	NA	NA			38	Kazal-like. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPOCK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,167833778,G,G&fts=all">p.S159F</a>
SPTA1	Missense_Mutation	p.L985I	A	A		7	Cancer Module	1	158624484	158624484	156	0.0512820512820513	NA	NA	NA			307	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158624484,A,A&fts=all">p.L985I</a>
SSH2	Nonsense_Mutation	p.Q78*	G	G		7	Cancer Module	17	28022521	28022521	194	0.381443298969072	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,28022521,G,G&fts=all">p.Q78*</a>
ST8SIA2	Missense_Mutation	p.R223L	G	G		7	Cancer Module	15	92987985	92987985	53	0.150943396226415	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST8SIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,92987985,G,G&fts=all">p.R223L</a>
SULT1C2	Splice_Site		G	G		7	Cancer Module	2	108921870	108921870	53	0.150943396226415	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT1C2&recr=Open">Click here</a>	
SUSD4	Missense_Mutation	p.G252E	C	C		7	Cancer Module	1	223402700	223402700	120	0.591666666666667	NA	NA	NA			17	Sushi 4. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUSD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,223402700,C,C&fts=all">p.G252E</a>
TACC2	Missense_Mutation	p.E922K	G	G		7	Cancer Module	10	124008295	124008295	213	0.366197183098592	NA	NA	NA			83			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124008295,G,G&fts=all">p.E922K</a>
TACC3	Splice_Site		G	G		7	Cancer Module	4	1742552	1742552	310	0.474193548387097	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC3&recr=Open">Click here</a>	
TACR3	Missense_Mutation	p.R425W	G	G		7	Cancer Module	4	104510964	104510964	391	0.219948849104859	NA	NA	NA			51			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,104510964,G,G&fts=all">p.R425W</a>
TDG	Missense_Mutation	p.P393S	C	C		7	Cancer Module	12	104380812	104380812	157	0.210191082802548	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104380812,C,C&fts=all">p.P393S</a>
TLL1	Missense_Mutation	p.S7F	C	C		7	Cancer Module	4	166795076	166795076	281	0.263345195729537	NA	NA	NA			77			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,166795076,C,C&fts=all">p.S7F</a>
TMEM200A	Missense_Mutation	p.S354L	C	C		7	Cancer Module	6	130762628	130762628	117	0.290598290598291	NA	NA	NA		p.S354L(2)	52			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM200A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,130762628,C,C&fts=all">p.S354L</a>
TMPRSS4	Missense_Mutation	p.P35S	C	C		7	Cancer Module	11	117969759	117969759	121	0.322314049586777	NA	NA	NA			19			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,117969759,C,C&fts=all">p.P35S</a>
TNFRSF10D	Missense_Mutation	p.S129R	T	T		7	Cancer Module	8	23004571	23004571	287	0.0174216027874564	NA	NA	NA			9			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFRSF10D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,23004571,T,T&fts=all">p.S129R</a>
TNR	Missense_Mutation	p.E263K	C	C		7	Cancer Module	1	175372465	175372465	76	0.605263157894737	NA	NA	NA		p.E263K(1)	177	Cys-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175372465,C,C&fts=all">p.E263K</a>
TNXB	Missense_Mutation	p.G2592S	C	C		7	Cancer Module	6	32025886	32025886	137	0.35036496350365	NA	NA	NA			8	Fibronectin type-III 18. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32025886,C,C&fts=all">p.G2592S</a>
TOX2	Missense_Mutation	p.P498S	C	C		7	Cancer Module	20	42697297	42697297	65	0.292307692307692	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,42697297,C,C&fts=all">p.P498S</a>
TRIM22	Missense_Mutation	p.E417K	G	G		7	Cancer Module	11	5730630	5730630	177	0.288135593220339	NA	NA	NA			23	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5730630,G,G&fts=all">p.E417K</a>
TTN	Nonsense_Mutation	p.W30051*	C	C		7	Cancer Module	2	179417474	179417474	155	0.529032258064516	NA	NA	NA			1448	Ig-like 136.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179417474,C,C&fts=all">p.W30051*</a>
TTN	Nonsense_Mutation	p.W27617*	C	C		7	Cancer Module	2	179428008	179428008	144	0.131944444444444	NA	NA	NA			1448	Fibronectin type-III 101. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179428008,C,C&fts=all">p.W27617*</a>
TTN	Nonsense_Mutation	p.Q23640*	G	G	rs547376963	7	Cancer Module	2	179439941	179439941	43	0.13953488372093	NA	NA	NA			1448	Fibronectin type-III 71. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179439941,G,G&fts=all">p.Q23640*</a>
TTN	Missense_Mutation	p.P269S	G	G		7	Cancer Module	2	179664323	179664323	126	0.119047619047619	NA	NA	NA			1448	ZIS1.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179664323,G,G&fts=all">p.P269S</a>
TUBB	Missense_Mutation	p.R390C	C	C	rs2394398	7	Cancer Module	6	30692007	30692007	128	0.2578125	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUBB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30692007,C,C&fts=all">p.R390C</a>
TUBGCP6	Missense_Mutation	p.P496S	G	G		7	Cancer Module	22	50665433	50665433	44	0.340909090909091	NA	NA	NA			45			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TUBGCP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,50665433,G,G&fts=all">p.P496S</a>
UBA6	Missense_Mutation	p.P294L	G	G		7	Cancer Module	4	68530923	68530923	213	0.267605633802817	NA	NA	NA			44			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,68530923,G,G&fts=all">p.P294L</a>
UGT2B15	Missense_Mutation	p.R174Q	C	C	rs377015117	7	Cancer Module	4	69535816	69535816	588	0.217687074829932	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69535816,C,C&fts=all">p.R174Q</a>
UGT8	Missense_Mutation	p.E102K	G	G		7	Cancer Module	4	115544340	115544340	261	0.471264367816092	NA	NA	NA		p.E102K(3)	31			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,115544340,G,G&fts=all">p.E102K</a>
USH2A	Missense_Mutation	p.L3537F	G	G	rs138656755	7	Cancer Module	1	215955515	215955515	148	0.587837837837838	NA	NA	NA			527	Fibronectin type-III 20. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,215955515,G,G&fts=all">p.L3537F</a>
VNN1	Missense_Mutation	p.G297E	C	C		7	Cancer Module	6	133013660	133013660	76	0.289473684210526	NA	NA	NA		p.G297V(1)	31	CN hydrolase. {ECO:0000255|PROSITE- ProRule:PRU00054}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VNN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,133013660,C,C&fts=all">p.G297E</a>
VWF	Missense_Mutation	p.R1315C	G	G	rs61749395	7	Cancer Module	12	6128641	6128641	165	0.303030303030303	NA	NA	NA			129	VWFA 1; binding site for platelet glycoprotein Ib. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,6128641,G,G&fts=all">p.R1315C</a>
WDR47	Missense_Mutation	p.P177T	G	G		7	Cancer Module	1	109554139	109554139	741	0.547908232118758	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR47&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,109554139,G,G&fts=all">p.P177T</a>
YAP1	Splice_Site	p.Q150Q	G	G		7	Cancer Module	11	102076805	102076805	88	0.318181818181818	NA	NA	NA			4			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YAP1&recr=Open">Click here</a>	
ZFPM2	Missense_Mutation	p.E700K	G	G		7	Cancer Module	8	106814408	106814408	78	0.179487179487179	NA	NA	NA			99			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFPM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,106814408,G,G&fts=all">p.E700K</a>
ZFPM2	Missense_Mutation	p.S822F	C	C		7	Cancer Module	8	106814775	106814775	35	0.4	NA	NA	NA			99			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFPM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,106814775,C,C&fts=all">p.S822F</a>
ZIC4	Missense_Mutation	p.S74L	G	G		7	Cancer Module	3	147108883	147108883	188	0.234042553191489	NA	NA	NA			57			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZIC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,147108883,G,G&fts=all">p.S74L</a>
ZMYM1	Missense_Mutation	p.S984P	T	T		7	Cancer Module	1	35580381	35580381	119	0.327731092436975	NA	NA	NA			31			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZMYM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,35580381,T,T&fts=all">p.S984P</a>
ZNF160	Missense_Mutation	p.H559Y	G	G	rs557481342	7	Cancer Module	19	53572112	53572112	287	0.219512195121951	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF160&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53572112,G,G&fts=all">p.H559Y</a>
ZNF333	Missense_Mutation	p.T432M	C	C		7	Cancer Module	19	14829434	14829434	123	0.178861788617886	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF333&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,14829434,C,C&fts=all">p.T432M</a>
ZNF681	Missense_Mutation	p.F42Y	A	A		7	Cancer Module	19	23938232	23938232	364	0.162087912087912	NA	NA	NA			21	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF681&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,23938232,A,A&fts=all">p.F42Y</a>
ACSM2A	Missense_Mutation	p.L287R	T	T		8	Cancer Gene	16	20482977	20482977	291	0.29553264604811	NA	NA	NA			51			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20482977,T,T&fts=all">p.L287R</a>
ADAMTSL3	Missense_Mutation	p.D189N	G	G		8	Cancer Gene	15	84488764	84488764	102	0.323529411764706	NA	NA	NA			130			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTSL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,84488764,G,G&fts=all">p.D189N</a>
ADCY10	Missense_Mutation	p.M54I	C	C		8	Cancer Gene	1	167873216	167873216	167	0.634730538922156	NA	NA	NA			63	Guanylate cyclase 1. {ECO:0000255|PROSITE-ProRule:PRU00099}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,167873216,C,C&fts=all">p.M54I</a>
ADCY5	Missense_Mutation	p.D86H	C	C		8	Cancer Gene	3	123167137	123167137	48	0.104166666666667	NA	NA	NA			60			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,123167137,C,C&fts=all">p.D86H</a>
AGAP1	Missense_Mutation	p.D191N	G	G	rs200056479	8	Cancer Gene	2	236659030	236659030	289	0.0207612456747405	NA	NA	NA			41	Small GTPase-like.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,236659030,G,G&fts=all">p.D191N</a>
AGPAT6	Missense_Mutation	p.R43C	C	C		8	Cancer Gene	8	41456785	41456785	246	0.239837398373984	NA	NA	NA			14			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGPAT6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,41456785,C,C&fts=all">p.R43C</a>
AK5	Missense_Mutation	p.T25I	C	C		8	Cancer Gene	1	78001632	78001632	89	0.550561797752809	NA	NA	NA			40			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AK5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,78001632,C,C&fts=all">p.T25I</a>
AMBRA1	Missense_Mutation	p.G1043D	C	C		8	Cancer Gene	11	46430068	46430068	61	0.278688524590164	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMBRA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,46430068,C,C&fts=all">p.G1043D</a>
ANKRD45	Missense_Mutation	p.R122C	G	G		8	Cancer Gene	1	173616117	173616117	148	0.662162162162162	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD45&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,173616117,G,G&fts=all">p.R122C</a>
ANO7	Missense_Mutation	p.S229F	C	C		8	Cancer Gene	2	242139610	242139610	52	0.557692307692308	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,242139610,C,C&fts=all">p.S229F</a>
ASB14	Missense_Mutation	p.L540Q	A	A		8	Cancer Gene	3	57310723	57310723	100	0.26	NA	NA	NA			5	SOCS box. {ECO:0000255|PROSITE- ProRule:PRU00194}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASB14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,57310723,A,A&fts=all">p.L540Q</a>
ASXL3	Missense_Mutation	p.G295E	G	G		8	Cancer Gene	18	31311936	31311936	124	0.0887096774193548	NA	NA	NA			43			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,31311936,G,G&fts=all">p.G295E</a>
ASXL3	Missense_Mutation	p.A1080T	G	G		8	Cancer Gene	18	31323050	31323050	97	0.134020618556701	NA	NA	NA			43	Ala-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,31323050,G,G&fts=all">p.A1080T</a>
ATRNL1	Missense_Mutation	p.D664N	G	G		8	Cancer Gene	10	117027811	117027811	153	0.392156862745098	NA	NA	NA			95			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATRNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,117027811,G,G&fts=all">p.D664N</a>
ATXN7L2	Missense_Mutation	p.E218K	G	G		8	Cancer Gene	1	110030378	110030378	125	0.448	NA	NA	NA			17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATXN7L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,110030378,G,G&fts=all">p.E218K</a>
ATXN7L2	Missense_Mutation	p.P410L	C	C		8	Cancer Gene	1	110032743	110032743	147	0.170068027210884	NA	NA	NA			17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATXN7L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,110032743,C,C&fts=all">p.P410L</a>
B3GNT8	Missense_Mutation	p.R39W	G	G		8	Cancer Gene	19	41932569	41932569	101	0.207920792079208	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B3GNT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41932569,G,G&fts=all">p.R39W</a>
BNC1	Missense_Mutation	p.R604C	G	G	rs368320013	8	Cancer Gene	15	83932172	83932172	115	0.252173913043478	NA	NA	NA		p.R611C(1)	56			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BNC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,83932172,G,G&fts=all">p.R604C</a>
C11orf84	Nonsense_Mutation	p.K220*	A	A		8	Cancer Gene	11	63586049	63586049	128	0.34375	NA	NA	NA			8	Pro-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C11orf84&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,63586049,A,A&fts=all">p.K220*</a>
C12orf36	Missense_Mutation	p.G55E	C	C		8	Cancer Gene	12	13529176	13529176	145	0.303448275862069	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,13529176,C,C&fts=all">p.G55E</a>
C12orf50	Missense_Mutation	p.R391Q	C	C		8	Cancer Gene	12	88376927	88376927	330	0.3	NA	NA	NA		p.R391Q(1)	34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf50&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,88376927,C,C&fts=all">p.R391Q</a>
C1orf173	Missense_Mutation	p.G1333E	C	C		8	Cancer Gene	1	75037396	75037396	261	0.593869731800766	NA	NA	NA			184	Glu-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf173&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75037396,C,C&fts=all">p.G1333E</a>
C20orf26	Missense_Mutation	p.S917N	G	G		8	Cancer Gene	20	20258056	20258056	152	0.302631578947368	NA	NA	NA			77			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,20258056,G,G&fts=all">p.S917N</a>
C3orf36	Missense_Mutation	p.R83K	C	C		8	Cancer Gene	3	133647400	133647400	31	0.516129032258065	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,133647400,C,C&fts=all">p.R83K</a>
CABS1	Missense_Mutation	p.D277N	G	G		8	Cancer Gene	4	71201585	71201585	218	0.192660550458716	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CABS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71201585,G,G&fts=all">p.D277N</a>
CACNA1E	Nonsense_Mutation	p.R411*	C	C		8	Cancer Gene	1	181685181	181685181	15	0.466666666666667	NA	NA	NA			204			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,181685181,C,C&fts=all">p.R411*</a>
CACNA1H	Missense_Mutation	p.R2287K	G	G		8	Cancer Gene	16	1270810	1270810	175	0.297142857142857	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1H&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,1270810,G,G&fts=all">p.R2287K</a>
CACNA1S	Missense_Mutation	p.K681T	T	T		8	Cancer Gene	1	201043655	201043655	99	0.121212121212121	NA	NA	NA			102			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1S&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,201043655,T,T&fts=all">p.K681T</a>
CCDC39	Missense_Mutation	p.E643K	C	C		8	Cancer Gene	3	180349328	180349328	110	0.490909090909091	NA	NA	NA			45			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,180349328,C,C&fts=all">p.E643K</a>
CCDC88C	Missense_Mutation	p.R1299C	G	G	rs142539336	8	Cancer Gene	14	91763720	91763720	83	0.0963855421686747	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC88C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,91763720,G,G&fts=all">p.R1299C</a>
CCNT2	Missense_Mutation	p.M728I	G	G	rs142947931	8	Cancer Gene	2	135712209	135712209	227	0.110132158590308	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCNT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,135712209,G,G&fts=all">p.M728I</a>
CD163L1	Missense_Mutation	p.D551H	C	C		8	Cancer Gene	12	7550968	7550968	224	0.236607142857143	NA	NA	NA			96	SRCR 5. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7550968,C,C&fts=all">p.D551H</a>
CDC42BPG	Missense_Mutation	p.V230M	C	C		8	Cancer Gene	11	64606693	64606693	123	0.260162601626016	NA	NA	NA			4			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC42BPG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,64606693,C,C&fts=all">p.V230M</a>
CDH20	Missense_Mutation	p.A500T	G	G		8	Cancer Gene	18	59206346	59206346	198	0.439393939393939	NA	NA	NA			61	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,59206346,G,G&fts=all">p.A500T</a>
CELF6	Missense_Mutation	p.P207L	G	G		8	Cancer Gene	15	72581541	72581541	10	0.3	NA	NA	NA			13	RRM 2. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELF6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,72581541,G,G&fts=all">p.P207L</a>
CGREF1	Missense_Mutation	p.P15S	G	G		8	Cancer Gene	2	27327192	27327192	103	0.135922330097087	NA	NA	NA			10			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CGREF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27327192,G,G&fts=all">p.P15S</a>
CHD5	Missense_Mutation	p.S310Y	G	G		8	Cancer Gene	1	6211157	6211157	66	0.196969696969697	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,6211157,G,G&fts=all">p.S310Y</a>
CHMP7	Missense_Mutation	p.P233S	C	C		8	Cancer Gene	8	23114012	23114012	319	0.278996865203762	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHMP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,23114012,C,C&fts=all">p.P233S</a>
CLEC16A	Missense_Mutation	p.V123I	G	G		8	Cancer Gene	16	11063041	11063041	132	0.0303030303030303	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC16A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,11063041,G,G&fts=all">p.V123I</a>
CMYA5	Missense_Mutation	p.S2029F	C	C		8	Cancer Gene	5	79030674	79030674	60	0.466666666666667	NA	NA	NA			128			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMYA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,79030674,C,C&fts=all">p.S2029F</a>
CNOT1	Missense_Mutation	p.P215S	G	G		8	Cancer Gene	16	58619405	58619405	85	0.235294117647059	NA	NA	NA			87			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNOT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,58619405,G,G&fts=all">p.P215S</a>
COG7	Missense_Mutation	p.R573Q	C	C	rs143639857	8	Cancer Gene	16	23415100	23415100	78	0.243589743589744	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COG7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23415100,C,C&fts=all">p.R573Q</a>
COL14A1	Missense_Mutation	p.D1080N	G	G		8	Cancer Gene	8	121290374	121290374	290	0.282758620689655	NA	NA	NA			119			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL14A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121290374,G,G&fts=all">p.D1080N</a>
COL21A1	Missense_Mutation	p.G111R	C	C		8	Cancer Gene	6	56044685	56044685	56	0.303571428571429	NA	NA	NA			41	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL21A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,56044685,C,C&fts=all">p.G111R</a>
CRISP3	Missense_Mutation	p.P29S	G	G		8	Cancer Gene	6	49705064	49705064	104	0.25	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49705064,G,G&fts=all">p.P29S</a>
CSMD1	Missense_Mutation	p.H2747Y	G	G		8	Cancer Gene	8	2855674	2855674	148	0.304054054054054	NA	NA	NA			25	Sushi 19. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2855674,G,G&fts=all">p.H2747Y</a>
CYP27C1	Missense_Mutation	p.E237K	C	C		8	Cancer Gene	2	127952921	127952921	76	0.526315789473684	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP27C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,127952921,C,C&fts=all">p.E237K</a>
CYP7B1	Missense_Mutation	p.H106Y	G	G		8	Cancer Gene	8	65528782	65528782	102	0.166666666666667	NA	NA	NA			28			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP7B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,65528782,G,G&fts=all">p.H106Y</a>
DAB2IP	Missense_Mutation	p.P341S	C	C		8	Cancer Gene	9	124526091	124526091	115	0.634782608695652	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAB2IP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,124526091,C,C&fts=all">p.P341S</a>
DCBLD1	Missense_Mutation	p.D536V	A	A		8	Cancer Gene	6	117866752	117866752	226	0.269911504424779	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCBLD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117866752,A,A&fts=all">p.D536V</a>
DEAF1	Missense_Mutation	p.P431S	G	G		8	Cancer Gene	11	674748	674748	208	0.235576923076923	NA	NA	NA			24	Interaction with LMO4. {ECO:0000250}.|Pro-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,674748,G,G&fts=all">p.P431S</a>
DIP2A	Nonsense_Mutation	p.W869*	G	G		8	Cancer Gene	21	47969780	47969780	190	0.310526315789474	NA	NA	NA			43			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIP2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,47969780,G,G&fts=all">p.W869*</a>
DNAH12	Missense_Mutation	p.Y340H	A	A		8	Cancer Gene	3	57489811	57489811	134	0.350746268656716	NA	NA	NA			25	Stem. {ECO:0000250}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,57489811,A,A&fts=all">p.Y340H</a>
DNAH12	Missense_Mutation	p.S293F	G	G		8	Cancer Gene	3	57493389	57493389	132	0.409090909090909	NA	NA	NA			25	Stem. {ECO:0000250}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,57493389,G,G&fts=all">p.S293F</a>
DNAH17	Missense_Mutation	p.E463K	C	C		8	Cancer Gene	17	76563146	76563146	56	0.214285714285714	NA	NA	NA			116	Stem. {ECO:0000250}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,76563146,C,C&fts=all">p.E463K</a>
DNAH8	Missense_Mutation	p.E1034K	G	G		8	Cancer Gene	6	38791368	38791368	217	0.368663594470046	NA	NA	NA			260			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38791368,G,G&fts=all">p.E1034K</a>
DNAH8	Missense_Mutation	p.A3524T	G	G		8	Cancer Gene	6	38897389	38897389	239	0.347280334728033	NA	NA	NA			260	AAA 5. {ECO:0000250}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,38897389,G,G&fts=all">p.A3524T</a>
DOCK3	Missense_Mutation	p.M242I	G	G		8	Cancer Gene	3	51127795	51127795	31	0.161290322580645	NA	NA	NA			45			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,51127795,G,G&fts=all">p.M242I</a>
DOCK3	Missense_Mutation	p.E434Q	G	G		8	Cancer Gene	3	51263127	51263127	202	0.257425742574257	NA	NA	NA			45	DHR-1.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,51263127,G,G&fts=all">p.E434Q</a>
DOCK7	Missense_Mutation	p.T401I	G	G		8	Cancer Gene	1	63096991	63096991	310	0.0225806451612903	NA	NA	NA			92			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,63096991,G,G&fts=all">p.T401I</a>
DOCK7	Missense_Mutation	p.S180L	G	G		8	Cancer Gene	1	63113970	63113970	180	0.572222222222222	NA	NA	NA			92			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,63113970,G,G&fts=all">p.S180L</a>
DOCK7	Missense_Mutation	p.P140S	G	G		8	Cancer Gene	1	63114187	63114187	63	0.587301587301587	NA	NA	NA			92			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,63114187,G,G&fts=all">p.P140S</a>
DPPA4	Missense_Mutation	p.P133S	G	G	rs267599537	8	Cancer Gene	3	109049653	109049653	161	0.354037267080745	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPPA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,109049653,G,G&fts=all">p.P133S</a>
DYSF	Missense_Mutation	p.D61N	G	G		8	Cancer Gene	2	71709042	71709042	39	0.179487179487179	NA	NA	NA			111	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYSF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,71709042,G,G&fts=all">p.D61N</a>
DYSF	Missense_Mutation	p.G1718R	G	G		8	Cancer Gene	2	71891546	71891546	111	0.432432432432432	NA	NA	NA			111			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYSF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,71891546,G,G&fts=all">p.G1718R</a>
EFHC1	Missense_Mutation	p.D433N	G	G		8	Cancer Gene	6	52343853	52343853	196	0.357142857142857	NA	NA	NA			27	DM10 3. {ECO:0000255|PROSITE- ProRule:PRU00665}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFHC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,52343853,G,G&fts=all">p.D433N</a>
EPHA6	Missense_Mutation	p.R268C	C	C		8	Cancer Gene	3	96706525	96706525	421	0.399049881235154	NA	NA	NA		p.R174C(3)	101			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,96706525,C,C&fts=all">p.R268C</a>
EPHA6	Missense_Mutation	p.D174N	G	G		8	Cancer Gene	3	97251345	97251345	92	0.25	NA	NA	NA			101	Eph LBD. {ECO:0000255|PROSITE- ProRule:PRU00883}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,97251345,G,G&fts=all">p.D174N</a>
FAM181A	Missense_Mutation	p.R57W	C	C	rs142299390	8	Cancer Gene	14	94394800	94394800	54	0.444444444444444	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM181A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94394800,C,C&fts=all">p.R57W</a>
FAM188B	Missense_Mutation	p.I595V	A	A		8	Cancer Gene	7	30911895	30911895	92	0.391304347826087	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM188B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,30911895,A,A&fts=all">p.I595V</a>
FAM19A1	Nonsense_Mutation	p.W116*	G	G		8	Cancer Gene	3	68587994	68587994	98	0.336734693877551	NA	NA	NA			7			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM19A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,68587994,G,G&fts=all">p.W116*</a>
FAM47A	Missense_Mutation	p.P483S	G	G		8	Cancer Gene	X	34148949	34148949	63	0.523809523809524	NA	NA	NA			97			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM47A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,34148949,G,G&fts=all">p.P483S</a>
FAM83B	Missense_Mutation	p.D503N	G	G		8	Cancer Gene	6	54805276	54805276	211	0.260663507109005	NA	NA	NA			71			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM83B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,54805276,G,G&fts=all">p.D503N</a>
FAT1	Missense_Mutation	p.H1844Y	G	G		8	Cancer Gene	4	187542210	187542210	101	0.366336633663366	NA	NA	NA			228	Cadherin 16. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,187542210,G,G&fts=all">p.H1844Y</a>
FBLN5	Missense_Mutation	p.E291K	C	C		8	Cancer Gene	14	92347754	92347754	158	0.481012658227848	NA	NA	NA			28	EGF-like 6; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBLN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,92347754,C,C&fts=all">p.E291K</a>
FMN2	Missense_Mutation	p.P1244L	C	C		8	Cancer Gene	1	240371843	240371843	54	0.12962962962963	NA	NA	NA		p.P1387L(1)	178	FH1.|Pro-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,240371843,C,C&fts=all">p.P1244L</a>
FNDC1	Missense_Mutation	p.D641N	G	G		8	Cancer Gene	6	159653465	159653465	154	0.350649350649351	NA	NA	NA			93			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,159653465,G,G&fts=all">p.D641N</a>
FNDC3A	Missense_Mutation	p.R1122C	C	C		8	Cancer Gene	13	49781298	49781298	192	0.270833333333333	NA	NA	NA			41	Fibronectin type-III 9. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,49781298,C,C&fts=all">p.R1122C</a>
FREM2	Missense_Mutation	p.R2527C	C	C		8	Cancer Gene	13	39435627	39435627	282	0.0177304964539007	NA	NA	NA			148			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,39435627,C,C&fts=all">p.R2527C</a>
FRMD3	Missense_Mutation	p.E551K	C	C		8	Cancer Gene	9	85862976	85862976	94	0.404255319148936	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,85862976,C,C&fts=all">p.E551K</a>
GAS2L2	Missense_Mutation	p.G429R	C	C		8	Cancer Gene	17	34073231	34073231	335	0.423880597014925	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAS2L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,34073231,C,C&fts=all">p.G429R</a>
GFOD1	Missense_Mutation	p.S300L	G	G		8	Cancer Gene	6	13365249	13365249	117	0.273504273504274	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GFOD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,13365249,G,G&fts=all">p.S300L</a>
GFRAL	Splice_Site	p.F317F	C	C		8	Cancer Gene	6	55223935	55223935	79	0.316455696202532	NA	NA	NA			48			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GFRAL&recr=Open">Click here</a>	
GOLGB1	Nonsense_Mutation	p.Q3150*	G	G		8	Cancer Gene	3	121386444	121386444	122	0.254098360655738	NA	NA	NA			119			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121386444,G,G&fts=all">p.Q3150*</a>
GPR125	Missense_Mutation	p.A1181T	C	C		8	Cancer Gene	4	22389753	22389753	339	0.0147492625368732	NA	NA	NA			56			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR125&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,22389753,C,C&fts=all">p.A1181T</a>
GPR155	Missense_Mutation	p.L42F	G	G		8	Cancer Gene	2	175346561	175346561	144	0.166666666666667	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR155&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,175346561,G,G&fts=all">p.L42F</a>
GSTA1	Missense_Mutation	p.E168K	C	C	rs148795539	8	Cancer Gene	6	52657698	52657698	198	0.313131313131313	NA	NA	NA			12	GST C-terminal.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,52657698,C,C&fts=all">p.E168K</a>
GSTA5	Missense_Mutation	p.S10F	G	G		8	Cancer Gene	6	52705583	52705583	123	0.455284552845528	NA	NA	NA			15	GST N-terminal.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,52705583,G,G&fts=all">p.S10F</a>
GUCA1C	Missense_Mutation	p.I142M	G	G		8	Cancer Gene	3	108634990	108634990	161	0.161490683229814	NA	NA	NA			14	EF-hand 4. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCA1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108634990,G,G&fts=all">p.I142M</a>
GUCA1C	Missense_Mutation	p.K141R	T	T		8	Cancer Gene	3	108634994	108634994	177	0.163841807909605	NA	NA	NA			14	EF-hand 4. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCA1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108634994,T,T&fts=all">p.K141R</a>
HECW1	Missense_Mutation	p.S633F	C	C		8	Cancer Gene	7	43484669	43484669	50	0.22	NA	NA	NA			125			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,43484669,C,C&fts=all">p.S633F</a>
HRNR	Missense_Mutation	p.R1953Q	C	C	rs144419544	8	Cancer Gene	1	152188247	152188247	1217	0.0336894001643385	NA	NA	NA		p.R1953Q(1)	192			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRNR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152188247,C,C&fts=all">p.R1953Q</a>
HTR1D	Missense_Mutation	p.P372L	G	G		8	Cancer Gene	1	23519598	23519598	259	0.208494208494208	NA	NA	NA			9			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR1D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,23519598,G,G&fts=all">p.P372L</a>
IGSF5	Missense_Mutation	p.G65D	G	G		8	Cancer Gene	21	41137555	41137555	76	0.210526315789474	NA	NA	NA			23	Ig-like V-type 1.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,41137555,G,G&fts=all">p.G65D</a>
INADL	Missense_Mutation	p.P1332L	C	C		8	Cancer Gene	1	62503684	62503684	236	0.622881355932203	NA	NA	NA			103			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INADL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62503684,C,C&fts=all">p.P1332L</a>
JMJD7-PLA2G4B	Missense_Mutation	p.P703S	C	C		8	Cancer Gene	15	42137892	42137892	103	0.262135922330097	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JMJD7-PLA2G4B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,42137892,C,C&fts=all">p.P703S</a>
KCNH5	Missense_Mutation	p.T861S	T	T		8	Cancer Gene	14	63174612	63174612	221	0.429864253393665	NA	NA	NA			99			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,63174612,T,T&fts=all">p.T861S</a>
KCNH6	Missense_Mutation	p.D46N	G	G	rs368030494	8	Cancer Gene	17	61601559	61601559	431	0.255220417633411	NA	NA	NA			54	PAS.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,61601559,G,G&fts=all">p.D46N</a>
KCTD2	Splice_Site	p.G150D	G	G		8	Cancer Gene	17	73049109	73049109	142	0.274647887323944	NA	NA	NA			3	BTB.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD2&recr=Open">Click here</a>	
KHDRBS2	Missense_Mutation	p.P83Q	G	G		8	Cancer Gene	6	62757871	62757871	171	0.269005847953216	NA	NA	NA			49	KH. {ECO:0000255|PROSITE- ProRule:PRU00117}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KHDRBS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,62757871,G,G&fts=all">p.P83Q</a>
KIAA0895L	Missense_Mutation	p.P108L	G	G		8	Cancer Gene	16	67214191	67214191	90	0.244444444444444	NA	NA	NA			17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0895L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,67214191,G,G&fts=all">p.P108L</a>
KIAA0895L	Missense_Mutation	p.P108T	G	G		8	Cancer Gene	16	67214192	67214192	89	0.247191011235955	NA	NA	NA			17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0895L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,67214192,G,G&fts=all">p.P108T</a>
KIAA1244	Splice_Site		G	G		8	Cancer Gene	6	138559769	138559769	152	0.256578947368421	NA	NA	NA			44			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1244&recr=Open">Click here</a>	
KIAA1324L	Missense_Mutation	p.T95A	T	T		8	Cancer Gene	7	86569389	86569389	417	0.534772182254197	NA	NA	NA			44			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1324L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,86569389,T,T&fts=all">p.T95A</a>
KIAA1429	Missense_Mutation	p.R313C	G	G		8	Cancer Gene	8	95539535	95539535	128	0.0390625	NA	NA	NA			66	Glu-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1429&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,95539535,G,G&fts=all">p.R313C</a>
KIR3DX1	Missense_Mutation	p.S225F	C	C		8	Cancer Gene	19	55048107	55048107	92	0.5	NA	NA	NA			24	Ig-like C2-type 2.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIR3DX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55048107,C,C&fts=all">p.S225F</a>
KIR3DX1	Missense_Mutation	p.F243S	T	T		8	Cancer Gene	19	55048161	55048161	113	0.433628318584071	NA	NA	NA			24	Ig-like C2-type 2.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIR3DX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55048161,T,T&fts=all">p.F243S</a>
KRT75	Missense_Mutation	p.G46D	C	C		8	Cancer Gene	12	52827952	52827952	111	0.036036036036036	NA	NA	NA			28	Gly-rich.|Head.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT75&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,52827952,C,C&fts=all">p.G46D</a>
KRT78	Missense_Mutation	p.R294Q	C	C		8	Cancer Gene	12	53238383	53238383	120	0.308333333333333	NA	NA	NA			18	Coil 2.|Rod.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT78&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53238383,C,C&fts=all">p.R294Q</a>
KRT80	Missense_Mutation	p.L118R	A	A		8	Cancer Gene	12	52579319	52579319	114	0.350877192982456	NA	NA	NA			5	Coil 1A.|Rod.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT80&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,52579319,A,A&fts=all">p.L118R</a>
KRT80	Missense_Mutation	p.A75T	C	C	rs370702758	8	Cancer Gene	12	52585464	52585464	240	0.0208333333333333	NA	NA	NA			5	Head.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT80&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,52585464,C,C&fts=all">p.A75T</a>
LATS2	Missense_Mutation	p.L841F	G	G	rs370483004	8	Cancer Gene	13	21555749	21555749	72	0.5	NA	NA	NA			45			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LATS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,21555749,G,G&fts=all">p.L841F</a>
LEMD2	Splice_Site		C	C		8	Cancer Gene	6	33748853	33748853	106	0.0471698113207547	NA	NA	NA		p.?(1)	9			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEMD2&recr=Open">Click here</a>	
LRP4	Missense_Mutation	p.T528A	T	T		8	Cancer Gene	11	46914639	46914639	100	0.32	NA	NA	NA			70			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,46914639,T,T&fts=all">p.T528A</a>
LRRK2	Missense_Mutation	p.P1173L	C	C		8	Cancer Gene	12	40696612	40696612	299	0.264214046822742	NA	NA	NA			181			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,40696612,C,C&fts=all">p.P1173L</a>
LRRK2	Missense_Mutation	p.E2503K	G	G		8	Cancer Gene	12	40761490	40761490	157	0.35031847133758	NA	NA	NA		p.E2510*(1)|p.E2503*(1)	181			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,40761490,G,G&fts=all">p.E2503K</a>
MC3R	Missense_Mutation	p.M156I	G	G		8	Cancer Gene	20	54824367	54824367	291	0.120274914089347	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MC3R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,54824367,G,G&fts=all">p.M156I</a>
MORC1	Missense_Mutation	p.G367E	C	C		8	Cancer Gene	3	108776265	108776265	360	0.252777777777778	NA	NA	NA		p.G367V(1)	105			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MORC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108776265,C,C&fts=all">p.G367E</a>
MPP7	Missense_Mutation	p.V312F	C	C		8	Cancer Gene	10	28408598	28408598	146	0.424657534246575	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28408598,C,C&fts=all">p.V312F</a>
MRPL15	Missense_Mutation	p.L195F	C	C		8	Cancer Gene	8	55059971	55059971	174	0.258620689655172	NA	NA	NA			10			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPL15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55059971,C,C&fts=all">p.L195F</a>
MYO18A	Missense_Mutation	p.S777F	G	G		8	Cancer Gene	17	27442106	27442106	78	0.397435897435897	NA	NA	NA			36	Myosin motor.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO18A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,27442106,G,G&fts=all">p.S777F</a>
NCOA6	Missense_Mutation	p.P1632S	G	G		8	Cancer Gene	20	33329166	33329166	178	0.0280898876404494	NA	NA	NA			107			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,33329166,G,G&fts=all">p.P1632S</a>
NDNF	Missense_Mutation	p.R357K	C	C	rs570604236	8	Cancer Gene	4	121958056	121958056	216	0.25462962962963	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDNF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,121958056,C,C&fts=all">p.R357K</a>
NES	Missense_Mutation	p.T651M	G	G		8	Cancer Gene	1	156642028	156642028	218	0.0275229357798165	NA	NA	NA			64	Tail.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NES&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,156642028,G,G&fts=all">p.T651M</a>
NIPAL2	Missense_Mutation	p.T147M	G	G	rs149567296	8	Cancer Gene	8	99234825	99234825	175	0.0285714285714286	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPAL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,99234825,G,G&fts=all">p.T147M</a>
NLRP13	Missense_Mutation	p.E120K	C	C	rs533550090	8	Cancer Gene	19	56436363	56436363	189	0.470899470899471	NA	NA	NA			109			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56436363,C,C&fts=all">p.E120K</a>
OBSCN	Missense_Mutation	p.H4465N	C	C		8	Cancer Gene	1	228487142	228487142	175	0.582857142857143	NA	NA	NA			223	Ig-like 46.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228487142,C,C&fts=all">p.H4465N</a>
OGT	Splice_Site	p.K177K	G	G		8	Cancer Gene	X	70764485	70764485	33	0.484848484848485	NA	NA	NA			43			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OGT&recr=Open">Click here</a>	
OR10G9	Missense_Mutation	p.L41R	T	T		8	Cancer Gene	11	123893841	123893841	205	0.0292682926829268	NA	NA	NA			61			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10G9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,123893841,T,T&fts=all">p.L41R</a>
OR10J1	Missense_Mutation	p.S320F	C	C	rs373330432	8	Cancer Gene	1	159410507	159410507	108	0.62037037037037	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10J1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,159410507,C,C&fts=all">p.S320F</a>
OR10R2	Missense_Mutation	p.T88A	A	A		8	Cancer Gene	1	158449929	158449929	345	0.628985507246377	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10R2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158449929,A,A&fts=all">p.T88A</a>
OR1F1	Missense_Mutation	p.P283L	C	C		8	Cancer Gene	16	3255094	3255094	199	0.276381909547739	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1F1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,3255094,C,C&fts=all">p.P283L</a>
OR2A12	Missense_Mutation	p.R121W	C	C	rs267601374	8	Cancer Gene	7	143792561	143792561	386	0.489637305699482	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2A12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143792561,C,C&fts=all">p.R121W</a>
OR2Z1	Missense_Mutation	p.A254V	C	C		8	Cancer Gene	19	8842151	8842151	125	0.264	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2Z1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8842151,C,C&fts=all">p.A254V</a>
OR4D9	Missense_Mutation	p.M199I	G	G		8	Cancer Gene	11	59282982	59282982	183	0.311475409836066	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4D9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,59282982,G,G&fts=all">p.M199I</a>
OR4E2	Missense_Mutation	p.S93F	C	C		8	Cancer Gene	14	22133574	22133574	422	0.146919431279621	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4E2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,22133574,C,C&fts=all">p.S93F</a>
OR4N5	Missense_Mutation	p.S74F	C	C		8	Cancer Gene	14	20612115	20612115	346	0.46242774566474	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4N5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,20612115,C,C&fts=all">p.S74F</a>
OR51A2	Missense_Mutation	p.A266V	G	G		8	Cancer Gene	11	4976147	4976147	271	0.022140221402214	NA	NA	NA			17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,4976147,G,G&fts=all">p.A266V</a>
OR6X1	Missense_Mutation	p.R225Q	C	C	rs140203672	8	Cancer Gene	11	123624553	123624553	169	0.378698224852071	NA	NA	NA			23			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6X1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,123624553,C,C&fts=all">p.R225Q</a>
OR7E24	Missense_Mutation	p.P39S	C	C		8	Cancer Gene	19	9361834	9361834	84	0.238095238095238	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7E24&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9361834,C,C&fts=all">p.P39S</a>
OR8K3	Missense_Mutation	p.S266F	C	C		8	Cancer Gene	11	56086579	56086579	149	0.308724832214765	NA	NA	NA			40			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR8K3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,56086579,C,C&fts=all">p.S266F</a>
OR9A2	Missense_Mutation	p.P283S	G	G		8	Cancer Gene	7	142723373	142723373	280	0.471428571428571	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,142723373,G,G&fts=all">p.P283S</a>
OR9A4	Missense_Mutation	p.E10K	G	G		8	Cancer Gene	7	141618703	141618703	505	0.491089108910891	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,141618703,G,G&fts=all">p.E10K</a>
OTOGL	Missense_Mutation	p.S829F	C	C		8	Cancer Gene	12	80663929	80663929	44	0.25	NA	NA	NA			23			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOGL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,80663929,C,C&fts=all">p.S829F</a>
OTOGL	Missense_Mutation	p.D1007N	G	G		8	Cancer Gene	12	80690724	80690724	18	0.222222222222222	NA	NA	NA			23	VWFD 3. {ECO:0000255|PROSITE- ProRule:PRU00580}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOGL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,80690724,G,G&fts=all">p.D1007N</a>
PAX1	Missense_Mutation	p.G163R	G	G		8	Cancer Gene	20	21687276	21687276	119	0.436974789915966	NA	NA	NA			38	Paired. {ECO:0000255|PROSITE- ProRule:PRU00381}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,21687276,G,G&fts=all">p.G163R</a>
PCDHA2	Missense_Mutation	p.E317K	G	G	rs17844246	8	Cancer Gene	5	140175498	140175498	67	0.552238805970149	NA	NA	NA			71	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140175498,G,G&fts=all">p.E317K</a>
PGM5	Missense_Mutation	p.V482L	G	G		8	Cancer Gene	9	71098929	71098929	188	0.308510638297872	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,71098929,G,G&fts=all">p.V482L</a>
PHLDB2	Missense_Mutation	p.S45F	C	C		8	Cancer Gene	3	111603058	111603058	322	0.43167701863354	NA	NA	NA			55			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHLDB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,111603058,C,C&fts=all">p.S45F</a>
PHLDB2	Missense_Mutation	p.S58F	C	C		8	Cancer Gene	3	111603097	111603097	292	0.400684931506849	NA	NA	NA			55			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHLDB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,111603097,C,C&fts=all">p.S58F</a>
PHTF1	Missense_Mutation	p.S530L	G	G	rs376954475	8	Cancer Gene	1	114248594	114248594	179	0.0279329608938547	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHTF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,114248594,G,G&fts=all">p.S530L</a>
PITPNM2	Missense_Mutation	p.P781S	G	G		8	Cancer Gene	12	123477109	123477109	160	0.03125	NA	NA	NA			39	DDHD. {ECO:0000255|PROSITE- ProRule:PRU00378}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PITPNM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,123477109,G,G&fts=all">p.P781S</a>
PKHD1	Missense_Mutation	p.S3679L	G	G		8	Cancer Gene	6	51523888	51523888	226	0.31858407079646	NA	NA	NA			304			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,51523888,G,G&fts=all">p.S3679L</a>
PKHD1L1	Missense_Mutation	p.H4076Y	C	C		8	Cancer Gene	8	110535015	110535015	67	0.298507462686567	NA	NA	NA			263			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110535015,C,C&fts=all">p.H4076Y</a>
PLA2G4C	Missense_Mutation	p.P307L	G	G		8	Cancer Gene	19	48581036	48581036	107	0.504672897196262	NA	NA	NA			38	PLA2c. {ECO:0000255|PROSITE- ProRule:PRU00555}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,48581036,G,G&fts=all">p.P307L</a>
PLCB4	Missense_Mutation	p.G876E	G	G		8	Cancer Gene	20	9417698	9417698	36	0.25	NA	NA	NA			87			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9417698,G,G&fts=all">p.G876E</a>
PLEC	Missense_Mutation	p.R3595W	G	G	rs571305150	8	Cancer Gene	8	144993617	144993617	142	0.429577464788732	NA	NA	NA		p.R3595W(1)|p.R3485W(1)	137	Globular 2.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,144993617,G,G&fts=all">p.R3595W</a>
PLEKHA7	Missense_Mutation	p.E794K	C	C		8	Cancer Gene	11	16822550	16822550	355	0.301408450704225	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,16822550,C,C&fts=all">p.E794K</a>
PLSCR2	Missense_Mutation	p.E164K	C	C		8	Cancer Gene	3	146173076	146173076	169	0.224852071005917	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLSCR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,146173076,C,C&fts=all">p.E164K</a>
POU3F3	Missense_Mutation	p.F329L	C	C		8	Cancer Gene	2	105472955	105472955	98	0.673469387755102	NA	NA	NA			12	POU-specific. {ECO:0000255|PROSITE- ProRule:PRU00530}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU3F3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,105472955,C,C&fts=all">p.F329L</a>
PREPL	Missense_Mutation	p.V141I	C	C	rs371112188	8	Cancer Gene	2	44569620	44569620	289	0.0173010380622837	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,44569620,C,C&fts=all">p.V141I</a>
PREX2	Missense_Mutation	p.D767N	G	G		8	Cancer Gene	8	69005888	69005888	209	0.267942583732057	NA	NA	NA			178			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,69005888,G,G&fts=all">p.D767N</a>
PRKCSH	Missense_Mutation	p.R139H	G	G	rs139991238	8	Cancer Gene	19	11552120	11552120	380	0.0157894736842105	NA	NA	NA			19			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCSH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,11552120,G,G&fts=all">p.R139H</a>
PRTG	Missense_Mutation	p.S369L	G	G		8	Cancer Gene	15	55971511	55971511	134	0.32089552238806	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRTG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,55971511,G,G&fts=all">p.S369L</a>
PRTG	Missense_Mutation	p.S160F	G	G	rs201047603	8	Cancer Gene	15	55976048	55976048	144	0.340277777777778	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRTG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,55976048,G,G&fts=all">p.S160F</a>
PSMA8	Missense_Mutation	p.G36E	G	G	rs267605136	8	Cancer Gene	18	23724527	23724527	170	0.494117647058824	NA	NA	NA		p.G36E(1)	16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMA8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,23724527,G,G&fts=all">p.G36E</a>
PYROXD2	Missense_Mutation	p.S118F	G	G		8	Cancer Gene	10	100159977	100159977	113	0.238938053097345	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PYROXD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,100159977,G,G&fts=all">p.S118F</a>
RASGRF1	Missense_Mutation	p.F776I	A	A		8	Cancer Gene	15	79296267	79296267	67	0.26865671641791	NA	NA	NA			71			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,79296267,A,A&fts=all">p.F776I</a>
RELL1	Missense_Mutation	p.R87H	C	C		8	Cancer Gene	4	37650951	37650951	443	0.0158013544018059	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,37650951,C,C&fts=all">p.R87H</a>
RHBDF2	Missense_Mutation	p.S12F	G	G		8	Cancer Gene	17	74477572	74477572	49	0.183673469387755	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHBDF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74477572,G,G&fts=all">p.S12F</a>
RHBG	Missense_Mutation	p.R84H	G	G		8	Cancer Gene	1	156347155	156347155	390	0.0128205128205128	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHBG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,156347155,G,G&fts=all">p.R84H</a>
RNF19A	Nonsense_Mutation	p.R160*	G	G		8	Cancer Gene	8	101299925	101299925	268	0.0186567164179104	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF19A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,101299925,G,G&fts=all">p.R160*</a>
RNF217	Missense_Mutation	p.P362S	C	C		8	Cancer Gene	6	125366558	125366558	81	0.259259259259259	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF217&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,125366558,C,C&fts=all">p.P362S</a>
SAMD9	Nonsense_Mutation	p.Q1086*	G	G		8	Cancer Gene	7	92732155	92732155	357	0.252100840336134	NA	NA	NA			88			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,92732155,G,G&fts=all">p.Q1086*</a>
SAMD9	Missense_Mutation	p.D1019N	C	C		8	Cancer Gene	7	92732356	92732356	307	0.0162866449511401	NA	NA	NA		p.D1019N(1)	88			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,92732356,C,C&fts=all">p.D1019N</a>
SCN11A	Missense_Mutation	p.P1577S	G	G		8	Cancer Gene	3	38888832	38888832	128	0.453125	NA	NA	NA			119			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38888832,G,G&fts=all">p.P1577S</a>
SCN11A	Missense_Mutation	p.Y1050C	T	T		8	Cancer Gene	3	38924794	38924794	136	0.0441176470588235	NA	NA	NA			119			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38924794,T,T&fts=all">p.Y1050C</a>
SCN11A	Missense_Mutation	p.E309K	C	C		8	Cancer Gene	3	38961460	38961460	200	0.22	NA	NA	NA			119			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38961460,C,C&fts=all">p.E309K</a>
SEC16B	Missense_Mutation	p.G378W	C	C		8	Cancer Gene	1	177927977	177927977	83	0.674698795180723	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEC16B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,177927977,C,C&fts=all">p.G378W</a>
SEMA3E	Nonsense_Mutation	p.Q755*	G	G		8	Cancer Gene	7	82996967	82996967	440	0.318181818181818	NA	NA	NA			51	Arg/Lys-rich (basic).		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82996967,G,G&fts=all">p.Q755*</a>
SERPINA10	Missense_Mutation	p.P34S	G	G		8	Cancer Gene	14	94756831	94756831	34	0.529411764705882	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINA10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94756831,G,G&fts=all">p.P34S</a>
SFXN1	Missense_Mutation	p.R315H	G	G	rs143516507	8	Cancer Gene	5	174953712	174953712	150	0.42	NA	NA	NA		p.R315H(1)	15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SFXN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,174953712,G,G&fts=all">p.R315H</a>
SH3RF2	Missense_Mutation	p.R510W	C	C		8	Cancer Gene	5	145435749	145435749	66	0.46969696969697	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3RF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,145435749,C,C&fts=all">p.R510W</a>
SHC3	Missense_Mutation	p.G581E	C	C		8	Cancer Gene	9	91628405	91628405	198	0.358585858585859	NA	NA	NA			28	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,91628405,C,C&fts=all">p.G581E</a>
SIRPD	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	20	1552685	1559342	NA	NA	2	-1.10005101381033	FALSE		NA	NA	NA		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIRPD&recr=Open">Click here</a>	
SLC13A1	Missense_Mutation	p.G319D	C	C		8	Cancer Gene	7	122769512	122769512	368	0.0135869565217391	NA	NA	NA			45			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC13A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,122769512,C,C&fts=all">p.G319D</a>
SLC16A14	Missense_Mutation	p.A439V	G	G		8	Cancer Gene	2	230910526	230910526	112	0.455357142857143	NA	NA	NA			28			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC16A14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,230910526,G,G&fts=all">p.A439V</a>
SLC1A2	Missense_Mutation	p.R56C	G	G		8	Cancer Gene	11	35336687	35336687	72	0.319444444444444	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,35336687,G,G&fts=all">p.R56C</a>
SLC2A12	Missense_Mutation	p.G410E	C	C		8	Cancer Gene	6	134349734	134349734	175	0.32	NA	NA	NA			17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC2A12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,134349734,C,C&fts=all">p.G410E</a>
SLC2A12	Missense_Mutation	p.G410R	C	C		8	Cancer Gene	6	134349735	134349735	174	0.316091954022989	NA	NA	NA			17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC2A12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,134349735,C,C&fts=all">p.G410R</a>
SLC34A2	Missense_Mutation	p.R179W	C	C	rs552759498	8	Cancer Gene	4	25669513	25669513	78	0.153846153846154	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC34A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,25669513,C,C&fts=all">p.R179W</a>
SLC44A4	Splice_Site		C	C		8	Cancer Gene	6	31832858	31832858	72	0.305555555555556	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC44A4&recr=Open">Click here</a>	
SLC47A2	Missense_Mutation	p.A475V	G	G		8	Cancer Gene	17	19584690	19584690	25	0.12	NA	NA	NA			9			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC47A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,19584690,G,G&fts=all">p.A475V</a>
SLC4A11	Missense_Mutation	p.S652F	G	G		8	Cancer Gene	20	3210015	3210015	130	0.353846153846154	NA	NA	NA			40	Membrane (bicarbonate transporter).		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,3210015,G,G&fts=all">p.S652F</a>
SNRNP48	Missense_Mutation	p.R294Q	G	G		8	Cancer Gene	6	7606338	7606338	292	0.0171232876712329	NA	NA	NA			10	Arg-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRNP48&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,7606338,G,G&fts=all">p.R294Q</a>
SOBP	Missense_Mutation	p.M39L	A	A		8	Cancer Gene	6	107824879	107824879	189	0.248677248677249	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,107824879,A,A&fts=all">p.M39L</a>
SORCS2	Missense_Mutation	p.R1055Q	G	G		8	Cancer Gene	4	7735104	7735104	29	0.137931034482759	NA	NA	NA			42			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,7735104,G,G&fts=all">p.R1055Q</a>
SORCS3	Missense_Mutation	p.G818E	G	G		8	Cancer Gene	10	106974277	106974277	121	0.206611570247934	NA	NA	NA			131			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,106974277,G,G&fts=all">p.G818E</a>
SPG7	Missense_Mutation	p.S257F	C	C		8	Cancer Gene	16	89595896	89595896	39	0.256410256410256	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPG7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,89595896,C,C&fts=all">p.S257F</a>
SPHKAP	Missense_Mutation	p.E858K	C	C	rs370506646	8	Cancer Gene	2	228882998	228882998	622	0.155948553054662	NA	NA	NA		p.E858*(2)	185			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228882998,C,C&fts=all">p.E858K</a>
SPHKAP	Missense_Mutation	p.G837E	C	C		8	Cancer Gene	2	228883060	228883060	680	0.491176470588235	NA	NA	NA			185			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPHKAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228883060,C,C&fts=all">p.G837E</a>
SRCRB4D	Missense_Mutation	p.A223V	G	G		8	Cancer Gene	7	76027035	76027035	124	0.556451612903226	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRCRB4D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,76027035,G,G&fts=all">p.A223V</a>
SRRM4	Splice_Site		G	G		8	Cancer Gene	12	119563185	119563185	84	0.226190476190476	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRRM4&recr=Open">Click here</a>	
SSTR1	Missense_Mutation	p.V290M	G	G		8	Cancer Gene	14	38679462	38679462	150	0.0933333333333333	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSTR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,38679462,G,G&fts=all">p.V290M</a>
STAB2	Missense_Mutation	p.G141R	G	G		8	Cancer Gene	12	104015823	104015823	68	0.279411764705882	NA	NA	NA			174			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104015823,G,G&fts=all">p.G141R</a>
STAB2	Missense_Mutation	p.F531C	T	T		8	Cancer Gene	12	104049069	104049069	319	0.329153605015674	NA	NA	NA			174			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104049069,T,T&fts=all">p.F531C</a>
TBC1D22A	Missense_Mutation	p.E411K	G	G		8	Cancer Gene	22	47432996	47432996	178	0.0224719101123595	NA	NA	NA			22	Rab-GAP TBC. {ECO:0000255|PROSITE- ProRule:PRU00163}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D22A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,47432996,G,G&fts=all">p.E411K</a>
TBX15	Missense_Mutation	p.S525F	G	G		8	Cancer Gene	1	119427590	119427590	116	0.198275862068966	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,119427590,G,G&fts=all">p.S525F</a>
TCF23	Missense_Mutation	p.L202F	C	C		8	Cancer Gene	2	27375694	27375694	141	0.184397163120567	NA	NA	NA			14			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCF23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27375694,C,C&fts=all">p.L202F</a>
TCHHL1	Missense_Mutation	p.S149R	T	T		8	Cancer Gene	1	152059713	152059713	313	0.115015974440895	NA	NA	NA			60			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCHHL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152059713,T,T&fts=all">p.S149R</a>
TCP11	Missense_Mutation	p.P417L	G	G		8	Cancer Gene	6	35086119	35086119	157	0.280254777070064	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCP11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,35086119,G,G&fts=all">p.P417L</a>
TEKT5	Missense_Mutation	p.E319K	C	C		8	Cancer Gene	16	10769947	10769947	140	0.328571428571429	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEKT5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,10769947,C,C&fts=all">p.E319K</a>
TEX10	Missense_Mutation	p.D731N	C	C		8	Cancer Gene	9	103082558	103082558	91	0.626373626373626	NA	NA	NA			38			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,103082558,C,C&fts=all">p.D731N</a>
TMEM198	Missense_Mutation	p.R283K	G	G		8	Cancer Gene	2	220413979	220413979	198	0.151515151515152	NA	NA	NA			16	Arg-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM198&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,220413979,G,G&fts=all">p.R283K</a>
TMPRSS6	Nonsense_Mutation	p.Q487*	G	G		8	Cancer Gene	22	37469668	37469668	298	0.365771812080537	NA	NA	NA			40	LDL-receptor class A 1. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37469668,G,G&fts=all">p.Q487*</a>
TNFSF8	Splice_Site	p.G80E	C	C	rs143691752	8	Cancer Gene	9	117668179	117668179	159	0.50314465408805	NA	NA	NA		p.G80E(1)	12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFSF8&recr=Open">Click here</a>	
TNIK	Missense_Mutation	p.E1005K	C	C		8	Cancer Gene	3	170802100	170802100	340	0.482352941176471	NA	NA	NA			62	Mediates interaction with NEDD4.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNIK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,170802100,C,C&fts=all">p.E1005K</a>
TNKS2	Missense_Mutation	p.V541M	G	G		8	Cancer Gene	10	93600411	93600411	353	0.0169971671388102	NA	NA	NA			48			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNKS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,93600411,G,G&fts=all">p.V541M</a>
TOPORS	Missense_Mutation	p.R863W	G	G		8	Cancer Gene	9	32541936	32541936	585	0.721367521367521	NA	NA	NA		p.R863R(1)	12	Interaction with TOP1.|Interaction with UBE2I.|Lys-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOPORS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,32541936,G,G&fts=all">p.R863W</a>
TRANK1	Missense_Mutation	p.E1697K	C	C		8	Cancer Gene	3	36874203	36874203	139	0.244604316546763	NA	NA	NA			73			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36874203,C,C&fts=all">p.E1697K</a>
TRIM55	Missense_Mutation	p.A513T	G	G	rs200934728	8	Cancer Gene	8	67086718	67086718	162	0.191358024691358	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM55&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,67086718,G,G&fts=all">p.A513T</a>
TRPM3	Missense_Mutation	p.R1204K	C	C		8	Cancer Gene	9	73164518	73164518	161	0.385093167701863	NA	NA	NA			95			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,73164518,C,C&fts=all">p.R1204K</a>
TRPM6	Missense_Mutation	p.L1300R	A	A		8	Cancer Gene	9	77377688	77377688	261	0.114942528735632	NA	NA	NA			126			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,77377688,A,A&fts=all">p.L1300R</a>
TRPM6	Missense_Mutation	p.G103E	C	C		8	Cancer Gene	9	77457104	77457104	438	0.36986301369863	NA	NA	NA			126			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,77457104,C,C&fts=all">p.G103E</a>
TTC21A	Missense_Mutation	p.G1214D	G	G		8	Cancer Gene	3	39179146	39179146	56	0.285714285714286	NA	NA	NA			50			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC21A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,39179146,G,G&fts=all">p.G1214D</a>
TTC21A	Missense_Mutation	p.H1300R	A	A		8	Cancer Gene	3	39180215	39180215	138	0.391304347826087	NA	NA	NA			50			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC21A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,39180215,A,A&fts=all">p.H1300R</a>
UBR1	Missense_Mutation	p.V522A	A	A		8	Cancer Gene	15	43339462	43339462	584	0.363013698630137	NA	NA	NA			58			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43339462,A,A&fts=all">p.V522A</a>
USP26	Missense_Mutation	p.G301E	C	C		8	Cancer Gene	X	132161347	132161347	110	0.609090909090909	NA	NA	NA			60	USP.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,132161347,C,C&fts=all">p.G301E</a>
USP26	Missense_Mutation	p.G301R	C	C		8	Cancer Gene	X	132161348	132161348	110	0.6	NA	NA	NA			60	USP.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,132161348,C,C&fts=all">p.G301R</a>
VANGL2	Frame_Shift_Del	p.PG49fs	TCCCG	TCCCG		8	Cancer Gene	1	160385924	160385928	233	0.0472103004291846	NA	NA	NA		p.G50W(1)	37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VANGL2&recr=Open">Click here</a>	
VSTM4	Missense_Mutation	p.K276N	T	T		8	Cancer Gene	10	50255037	50255037	496	0.032258064516129	NA	NA	NA			31			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VSTM4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,50255037,T,T&fts=all">p.K276N</a>
WDR59	Missense_Mutation	p.H967Y	G	G		8	Cancer Gene	16	74908133	74908133	33	0.393939393939394	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR59&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,74908133,G,G&fts=all">p.H967Y</a>
WDR62	Missense_Mutation	p.S1253L	C	C		8	Cancer Gene	19	36594488	36594488	76	0.486842105263158	NA	NA	NA			43			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR62&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36594488,C,C&fts=all">p.S1253L</a>
WFIKKN2	Missense_Mutation	p.V266L	G	G		8	Cancer Gene	17	48917445	48917445	95	0.336842105263158	NA	NA	NA			29	Ig-like C2-type.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WFIKKN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,48917445,G,G&fts=all">p.V266L</a>
WIPF2	Missense_Mutation	p.P268L	C	C		8	Cancer Gene	17	38421231	38421231	245	0.273469387755102	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WIPF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38421231,C,C&fts=all">p.P268L</a>
WSCD1	Missense_Mutation	p.R37Q	G	G		8	Cancer Gene	17	5984088	5984088	23	0.739130434782609	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WSCD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,5984088,G,G&fts=all">p.R37Q</a>
WWC2	Missense_Mutation	p.K1173N	G	G		8	Cancer Gene	4	184236822	184236822	60	0.45	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WWC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,184236822,G,G&fts=all">p.K1173N</a>
XIRP2	Missense_Mutation	p.E408K	G	G		8	Cancer Gene	2	168098367	168098367	318	0.122641509433962	NA	NA	NA			315			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,168098367,G,G&fts=all">p.E408K</a>
ZC3H4	Missense_Mutation	p.P532S	G	G		8	Cancer Gene	19	47575817	47575817	14	0.428571428571429	NA	NA	NA			41	Pro-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,47575817,G,G&fts=all">p.P532S</a>
ZER1	Nonsense_Mutation	p.W548*	C	C		8	Cancer Gene	9	131503908	131503908	133	0.586466165413534	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZER1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,131503908,C,C&fts=all">p.W548*</a>
ZFHX4	Missense_Mutation	p.S1564F	C	C		8	Cancer Gene	8	77763848	77763848	90	0.277777777777778	NA	NA	NA			432			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFHX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,77763848,C,C&fts=all">p.S1564F</a>
ZFYVE26	Missense_Mutation	p.R767C	G	G		8	Cancer Gene	14	68264422	68264422	83	0.44578313253012	NA	NA	NA			94			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFYVE26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,68264422,G,G&fts=all">p.R767C</a>
ZNF135	Missense_Mutation	p.S544F	C	C	rs373984435	8	Cancer Gene	19	58579609	58579609	106	0.433962264150943	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF135&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58579609,C,C&fts=all">p.S544F</a>
ZNF197	Missense_Mutation	p.E875K	G	G	rs61751651	8	Cancer Gene	3	44685245	44685245	318	0.0157232704402516	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF197&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,44685245,G,G&fts=all">p.E875K</a>
ZNF335	Missense_Mutation	p.P300S	G	G		8	Cancer Gene	20	44596190	44596190	111	0.324324324324324	NA	NA	NA			51			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF335&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,44596190,G,G&fts=all">p.P300S</a>
ZNF605	Missense_Mutation	p.R528I	C	C		8	Cancer Gene	12	133502395	133502395	64	0.375	NA	NA	NA			28			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF605&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,133502395,C,C&fts=all">p.R528I</a>
ZNF609	Missense_Mutation	p.P492L	C	C		8	Cancer Gene	15	64966528	64966528	98	0.346938775510204	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF609&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,64966528,C,C&fts=all">p.P492L</a>
ZNF665	Missense_Mutation	p.R198K	C	C		8	Cancer Gene	19	53669150	53669150	242	0.18595041322314	NA	NA	NA		p.R133I(1)	35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF665&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,53669150,C,C&fts=all">p.R198K</a>
ZNF81	Missense_Mutation	p.P637L	C	C		8	Cancer Gene	X	47775955	47775955	54	0.703703703703704	NA	NA	NA			4			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF81&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,47775955,C,C&fts=all">p.P637L</a>
ZSCAN18	Missense_Mutation	p.P279S	G	G		8	Cancer Gene	19	58598351	58598351	88	0.295454545454545	NA	NA	NA			19			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58598351,G,G&fts=all">p.P279S</a>
ZSCAN29	Missense_Mutation	p.N477I	T	T		8	Cancer Gene	15	43656373	43656373	202	0.326732673267327	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN29&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43656373,T,T&fts=all">p.N477I</a>
ZSCAN5B	Missense_Mutation	p.S368F	G	G		8	Cancer Gene	19	56701581	56701581	109	0.458715596330275	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56701581,G,G&fts=all">p.S368F</a>
C9orf53	Copy Number	Deleted	NA	NA	NA	9	VUS	9	21971209	22029516	NA	NA	4	-1.6519942592184	FALSE		NA	NA	NA		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf53&recr=Open">Click here</a>	
CDKN2BAS	Copy Number	Deleted	NA	NA	NA	9	VUS	9	21971209	22029516	NA	NA	4	-1.6519942592184	FALSE		NA	NA	NA		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN2BAS&recr=Open">Click here</a>	
AMER3	Missense_Mutation	p.P635S	C	C		10	SNP	2	131521548	131521548	43	0.209302325581395	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMER3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,131521548,C,C&fts=all">p.P635S</a>
C14orf166B	Missense_Mutation	p.V397I	G	G		10	SNP	14	77327120	77327120	142	0.5	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C14orf166B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,77327120,G,G&fts=all">p.V397I</a>
DGAT1	Missense_Mutation	p.R219P	C	C		10	SNP	8	145541944	145541944	61	0.39344262295082	NA	NA	NA			9			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGAT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145541944,C,C&fts=all">p.R219P</a>
ETNPPL	Missense_Mutation	p.D91N	C	C		10	SNP	4	109677593	109677593	131	0.229007633587786	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETNPPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,109677593,C,C&fts=all">p.D91N</a>
FAXC	Missense_Mutation	p.T341I	G	G		10	SNP	6	99729248	99729248	121	0.363636363636364	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAXC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,99729248,G,G&fts=all">p.T341I</a>
FOCAD	Missense_Mutation	p.R1159G	C	C	rs367733127	10	SNP	9	20944693	20944693	240	0.791666666666667	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOCAD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,20944693,C,C&fts=all">p.R1159G</a>
HECTD4	Missense_Mutation	p.M4163I	C	C		10	SNP	12	112601039	112601039	100	0.37	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECTD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,112601039,C,C&fts=all">p.M4163I</a>
HECTD4	Missense_Mutation	p.S957L	G	G		10	SNP	12	112694143	112694143	223	0.291479820627803	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECTD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,112694143,G,G&fts=all">p.S957L</a>
ITIH6	Missense_Mutation	p.A459T	C	C		10	SNP	X	54785132	54785132	29	0.655172413793103	NA	NA	NA				VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,54785132,C,C&fts=all">p.A459T</a>
LAMP5	Missense_Mutation	p.R113C	C	C		10	SNP	20	9496746	9496746	50	0.4	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9496746,C,C&fts=all">p.R113C</a>
MALAT1	lincRNA		C	C	rs191770790	10	SNP	11	65273864	65273864	42	0.285714285714286	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MALAT1&recr=Open">Click here</a>	
MLK4	Missense_Mutation	p.S1026F	C	C		10	SNP	1	233518423	233518423	139	0.381294964028777	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,233518423,C,C&fts=all">p.S1026F</a>
MROH2B	Missense_Mutation	p.D1083N	C	C		10	SNP	5	41010070	41010070	103	0.281553398058252	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41010070,C,C&fts=all">p.D1083N</a>
MROH7	Missense_Mutation	p.S1213F	C	C		10	SNP	1	55172181	55172181	184	0.559782608695652	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,55172181,C,C&fts=all">p.S1213F</a>
NELFE	Nonsense_Mutation	p.Q128*	G	G		10	SNP	6	31922858	31922858	201	0.248756218905473	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NELFE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31922858,G,G&fts=all">p.Q128*</a>
NKAIN3	Missense_Mutation	p.L38F	C	C		10	SNP	8	63492155	63492155	179	0.307262569832402	NA	NA	NA			13			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKAIN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,63492155,C,C&fts=all">p.L38F</a>
NT5C3A	Missense_Mutation	p.T61I	G	G		10	SNP	7	33066484	33066484	278	0.0179856115107914	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NT5C3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,33066484,G,G&fts=all">p.T61I</a>
PCED1B	Missense_Mutation	p.E57K	G	G		10	SNP	12	47629015	47629015	56	0.303571428571429	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCED1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,47629015,G,G&fts=all">p.E57K</a>
RP11-731F5.1	lincRNA		G	G		10	SNP	14	106066640	106066640	34	0.176470588235294	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-731F5.1&recr=Open">Click here</a>	
SLC52A2	Missense_Mutation	p.P64S	C	C		10	SNP	8	145584522	145584522	158	0.234177215189873	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC52A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145584522,C,C&fts=all">p.P64S</a>
TENM1	Missense_Mutation	p.R1787K	C	C		10	SNP	X	123538891	123538891	102	0.588235294117647	NA	NA	NA						MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,123538891,C,C&fts=all">p.R1787K</a>
UNC79	Nonsense_Mutation	p.R559*	C	C		10	SNP	14	94041539	94041539	157	0.452229299363057	NA	NA	NA			118			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC79&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94041539,C,C&fts=all">p.R559*</a>
UNC79	Missense_Mutation	p.P1785S	C	C		10	SNP	14	94103612	94103612	50	0.56	NA	NA	NA			118			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC79&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94103612,C,C&fts=all">p.P1785S</a>
ZNF250	Missense_Mutation	p.I523F	T	T		10	SNP	8	146107016	146107016	52	0.0769230769230769	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF250&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,146107016,T,T&fts=all">p.I523F</a>
ZNF792	Missense_Mutation	p.E170G	T	T		10	SNP	19	35450250	35450250	592	0.222972972972973	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF792&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,35450250,T,T&fts=all">p.E170G</a>
AARS2	Silent	p.K922K	C	C		11	Filtered Calls	6	44268920	44268920	107	0.299065420560748	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AARS2&recr=Open">Click here</a>	
AASDH	Silent	p.S592S	G	G		11	Filtered Calls	4	57216141	57216141	146	0.301369863013699	NA	NA	NA			40	Acyl carrier. {ECO:0000255|PROSITE- ProRule:PRU00258}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AASDH&recr=Open">Click here</a>	
ACHE	Silent	p.Y457Y	G	G		11	Filtered Calls	7	100490137	100490137	226	0.0221238938053097	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACHE&recr=Open">Click here</a>	
ADAM2	Intron		G	G		11	Filtered Calls	8	39624355	39624355	118	0.338983050847458	NA	NA	NA			53			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	
ADAMTS10	Silent	p.V636V	C	C		11	Filtered Calls	19	8654462	8654462	88	0.397727272727273	NA	NA	NA			53	Cys-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS10&recr=Open">Click here</a>	
ADAMTS12	Intron		G	G		11	Filtered Calls	5	33549496	33549496	201	0.348258706467662	NA	NA	NA			216			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS12&recr=Open">Click here</a>	
ADAMTS14	Silent	p.Y259Y	C	C		11	Filtered Calls	10	72468441	72468441	287	0.024390243902439	NA	NA	NA			50	Peptidase M12B. {ECO:0000255|PROSITE- ProRule:PRU00276}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS14&recr=Open">Click here</a>	
ADPRHL1	Silent	p.S40S	G	G	rs537275759	11	Filtered Calls	13	114107633	114107633	193	0.238341968911917	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADPRHL1&recr=Open">Click here</a>	
AGBL4	Silent	p.I409I	G	G		11	Filtered Calls	1	49052716	49052716	30	0.433333333333333	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGBL4&recr=Open">Click here</a>	
AGBL4	Silent	p.V256V	G	G		11	Filtered Calls	1	49119080	49119080	39	0.435897435897436	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGBL4&recr=Open">Click here</a>	
AHNAK	5'Flank		G	G		11	Filtered Calls	11	62286659	62286659	409	0.0146699266503667	NA	NA	NA			268			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHNAK&recr=Open">Click here</a>	
AHSA1	Intron		C	C		11	Filtered Calls	14	77931933	77931933	146	0.452054794520548	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHSA1&recr=Open">Click here</a>	
AKAP11	Silent	p.I1677I	C	C	rs181261991	11	Filtered Calls	13	42877913	42877913	86	0.372093023255814	NA	NA	NA		p.I1677I(1)	56			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP11&recr=Open">Click here</a>	
AKNAD1	Silent	p.D170D	G	G		11	Filtered Calls	1	109394777	109394777	472	0.483050847457627	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKNAD1&recr=Open">Click here</a>	
AKR1CL1	5'Flank		G	G		11	Filtered Calls	10	5203902	5203902	52	0.384615384615385	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1CL1&recr=Open">Click here</a>	
ANXA1	Silent	p.L92L	G	G		11	Filtered Calls	9	75775184	75775184	304	0.348684210526316	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA1&recr=Open">Click here</a>	
AOC1	Silent	p.F326F	C	C		11	Filtered Calls	7	150554536	150554536	81	0.419753086419753	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AOC1&recr=Open">Click here</a>	
ARHGAP28	Intron		G	G		11	Filtered Calls	18	6898522	6898522	192	0.546875	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP28&recr=Open">Click here</a>	
ARHGAP30	Silent	p.L1003L	G	G		11	Filtered Calls	1	161017804	161017804	195	0.651282051282051	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP30&recr=Open">Click here</a>	
ARHGAP8	3'UTR		C	C	rs573395597	11	Filtered Calls	22	45258441	45258441	68	0.411764705882353	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP8&recr=Open">Click here</a>	
ARHGAP9	Intron		G	G		11	Filtered Calls	12	57870445	57870445	177	0.305084745762712	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP9&recr=Open">Click here</a>	
ARHGDIB	Intron		C	C		11	Filtered Calls	12	15097704	15097704	233	0.334763948497854	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGDIB&recr=Open">Click here</a>	
ARMC12	Silent	p.G261G	C	C		11	Filtered Calls	6	35716407	35716407	100	0.24	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC12&recr=Open">Click here</a>	
ARMC9	Silent	p.A254A	C	C		11	Filtered Calls	2	232100076	232100076	62	0.370967741935484	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC9&recr=Open">Click here</a>	
ASAH1	Silent	p.I282I	G	G		11	Filtered Calls	8	17917152	17917152	236	0.338983050847458	NA	NA	NA			9			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASAH1&recr=Open">Click here</a>	
ASIC2	Intron		G	G		11	Filtered Calls	17	31344710	31344710	207	0.260869565217391	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASIC2&recr=Open">Click here</a>	
ASTN2	Intron		G	G		11	Filtered Calls	9	119738474	119738474	37	0.513513513513513	NA	NA	NA			102			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN2&recr=Open">Click here</a>	
ATG2A	Intron		G	G		11	Filtered Calls	11	64665225	64665225	119	0.361344537815126	NA	NA	NA			55			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATG2A&recr=Open">Click here</a>	
ATP1A3	Silent	p.Y905Y	G	G		11	Filtered Calls	19	42473599	42473599	241	0.020746887966805	NA	NA	NA			52			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP1A3&recr=Open">Click here</a>	
ATP5J2-PTCD1	Intron		C	C		11	Filtered Calls	7	99051711	99051711	292	0.205479452054795	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP5J2-PTCD1&recr=Open">Click here</a>	
ATP6V0D1	IGR		C	C		11	Filtered Calls	16	67470808	67470808	156	0.0256410256410256	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP6V0D1&recr=Open">Click here</a>	
ATRNL1	Silent	p.F205F	C	C		11	Filtered Calls	10	116887480	116887480	66	0.272727272727273	NA	NA	NA			95	CUB. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATRNL1&recr=Open">Click here</a>	
ATXN7	Silent	p.P247P	C	C	rs371763698	11	Filtered Calls	3	63965832	63965832	137	0.204379562043796	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATXN7&recr=Open">Click here</a>	
B3GNT2	Silent	p.E62E	G	G		11	Filtered Calls	2	62449541	62449541	563	0.0124333925399645	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B3GNT2&recr=Open">Click here</a>	
BAP1	Intron		G	G		11	Filtered Calls	3	52437144	52437144	111	0.405405405405405	NA	NA	NA			180			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAP1&recr=Open">Click here</a>	
BAP1	Intron		G	G		11	Filtered Calls	3	52437148	52437148	108	0.416666666666667	NA	NA	NA			180			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BAP1&recr=Open">Click here</a>	
BEST3	Silent	p.I656I	G	G		11	Filtered Calls	12	70048726	70048726	204	0.323529411764706	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BEST3&recr=Open">Click here</a>	
BFSP2	Silent	p.I271I	C	C		11	Filtered Calls	3	133169230	133169230	159	0.50314465408805	NA	NA	NA			13	Rod.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BFSP2&recr=Open">Click here</a>	
BPIFB1	Silent	p.V177V	G	G		11	Filtered Calls	20	31879728	31879728	175	0.274285714285714	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPIFB1&recr=Open">Click here</a>	
BTBD11	Silent	p.I425I	C	C	rs373812031	11	Filtered Calls	12	107914403	107914403	107	0.252336448598131	NA	NA	NA			53			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTBD11&recr=Open">Click here</a>	
BTNL8	Intron		C	C		11	Filtered Calls	5	180335576	180335576	10	0.5	NA	NA	NA			28			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTNL8&recr=Open">Click here</a>	
BUB1B	Silent	p.P557P	C	C		11	Filtered Calls	15	40494832	40494832	269	0.241635687732342	NA	NA	NA			36			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BUB1B&recr=Open">Click here</a>	
C12orf52	Silent	p.L140L	C	C		11	Filtered Calls	12	113629232	113629232	115	0.31304347826087	NA	NA	NA			5	Interaction with RBPJ/RBPSUH.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf52&recr=Open">Click here</a>	
C14orf93	Silent	p.F174F	G	G		11	Filtered Calls	14	23467711	23467711	48	0.520833333333333	NA	NA	NA			17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C14orf93&recr=Open">Click here</a>	
C1orf168	Silent	p.R430R	C	C		11	Filtered Calls	1	57216814	57216814	187	0.20855614973262	NA	NA	NA			46			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf168&recr=Open">Click here</a>	
C1orf94	Silent	p.S322S	C	C		11	Filtered Calls	1	34663471	34663471	117	0.162393162393162	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf94&recr=Open">Click here</a>	
C20orf26	Intron		C	C		11	Filtered Calls	20	20208889	20208889	112	0.0982142857142857	NA	NA	NA			77			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf26&recr=Open">Click here</a>	
C3orf38	3'UTR		G	G		11	Filtered Calls	3	88205523	88205523	193	0.238341968911917	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3orf38&recr=Open">Click here</a>	
CACNA1B	Silent	p.F1688F	C	C		11	Filtered Calls	9	140972680	140972680	54	0.611111111111111	NA	NA	NA			80			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1B&recr=Open">Click here</a>	
CACNA1C	Intron		A	A		11	Filtered Calls	12	2706460	2706460	311	0.254019292604502	NA	NA	NA			132			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1C&recr=Open">Click here</a>	
CACNG7	Intron		G	G		11	Filtered Calls	19	54417848	54417848	84	0.166666666666667	NA	NA	NA			23			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG7&recr=Open">Click here</a>	
CADM2	Silent	p.F434F	C	C		11	Filtered Calls	3	86115927	86115927	164	0.304878048780488	NA	NA	NA			38			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADM2&recr=Open">Click here</a>	
CAMK2B	Intron		C	C		11	Filtered Calls	7	44266180	44266180	96	0.645833333333333	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK2B&recr=Open">Click here</a>	
CAND2	Silent	p.P932P	C	C		11	Filtered Calls	3	12859227	12859227	291	0.261168384879725	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAND2&recr=Open">Click here</a>	
CARD11	Silent	p.I573I	G	G		11	Filtered Calls	7	2968267	2968267	285	0.505263157894737	NA	NA	NA		p.I566I(1)	150			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARD11&recr=Open">Click here</a>	
CATSPERB	Silent	p.S397S	T	T		11	Filtered Calls	14	92136254	92136254	153	0.130718954248366	NA	NA	NA			54			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERB&recr=Open">Click here</a>	
CATSPERB	Silent	p.I172I	G	G		11	Filtered Calls	14	92170996	92170996	194	0.175257731958763	NA	NA	NA			54			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERB&recr=Open">Click here</a>	
CBFA2T3	Silent	p.S155S	C	C		11	Filtered Calls	16	88958808	88958808	51	0.0784313725490196	NA	NA	NA			17	Mediates interaction with PDE7A (in isoform 2).|Mediates localization to the nucleus. {ECO:0000250}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBFA2T3&recr=Open">Click here</a>	
CBFA2T3	Silent	p.H116H	A	A		11	Filtered Calls	16	88964517	88964517	171	0.257309941520468	NA	NA	NA			17	Mediates interaction with PDE7A (in isoform 2).|Mediates localization to the nucleus. {ECO:0000250}.|Required for nucleolar targeting (in isoform 1).		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBFA2T3&recr=Open">Click here</a>	
CCDC102A	Silent	p.A390A	G	G		11	Filtered Calls	16	57552058	57552058	284	0.320422535211268	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC102A&recr=Open">Click here</a>	
CCDC27	Silent	p.S58S	G	G		11	Filtered Calls	1	3669219	3669219	243	0.0864197530864197	NA	NA	NA			36			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC27&recr=Open">Click here</a>	
CCDC77	Silent	p.V457V	C	C		11	Filtered Calls	12	550990	550990	203	0.339901477832512	NA	NA	NA			19			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC77&recr=Open">Click here</a>	
CCKBR	IGR		G	G		11	Filtered Calls	11	6292240	6292240	148	0.310810810810811	NA	NA	NA			61			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCKBR&recr=Open">Click here</a>	
CD101	Intron		C	C		11	Filtered Calls	1	117564611	117564611	130	0.153846153846154	NA	NA	NA			49			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD101&recr=Open">Click here</a>	
CD101	Intron		C	C		11	Filtered Calls	1	117564612	117564612	129	0.155038759689922	NA	NA	NA			49			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD101&recr=Open">Click here</a>	
CD28	Intron		G	G		11	Filtered Calls	2	204571413	204571413	156	0.384615384615385	NA	NA	NA			13			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD28&recr=Open">Click here</a>	
CDH4	Silent	p.V341V	C	C		11	Filtered Calls	20	60448929	60448929	179	0.290502793296089	NA	NA	NA			74	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH4&recr=Open">Click here</a>	
CELSR1	3'UTR		C	C		11	Filtered Calls	22	46759065	46759065	287	0.0174216027874564	NA	NA	NA			95			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR1&recr=Open">Click here</a>	
CEP192	Silent	p.L785L	T	T		11	Filtered Calls	18	13049145	13049145	66	0.621212121212121	NA	NA	NA			71			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP192&recr=Open">Click here</a>	
CHAT	Silent	p.Q141Q	G	G		11	Filtered Calls	10	50827806	50827806	68	0.308823529411765	NA	NA	NA			56			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHAT&recr=Open">Click here</a>	
CHD5	Silent	p.I761I	G	G		11	Filtered Calls	1	6202341	6202341	201	0.228855721393035	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD5&recr=Open">Click here</a>	
CHD8	Silent	p.D722D	G	G		11	Filtered Calls	14	21881132	21881132	47	0.446808510638298	NA	NA	NA			85			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD8&recr=Open">Click here</a>	
CHST12	Silent	p.A111A	C	C	rs149805994	11	Filtered Calls	7	2472607	2472607	169	0.254437869822485	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST12&recr=Open">Click here</a>	
CHST12	Silent	p.F146F	C	C		11	Filtered Calls	7	2472712	2472712	354	0.0169491525423729	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST12&recr=Open">Click here</a>	
CLCN4	Silent	p.I453I	C	C		11	Filtered Calls	X	10176600	10176600	83	0.614457831325301	NA	NA	NA		p.I453I(1)	36			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN4&recr=Open">Click here</a>	
CLCN5	Silent	p.Y672Y	C	C		11	Filtered Calls	X	49855409	49855409	40	0.575	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN5&recr=Open">Click here</a>	
CLPTM1L	Silent	p.F436F	G	G	rs202096751	11	Filtered Calls	5	1322999	1322999	324	0.0185185185185185	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLPTM1L&recr=Open">Click here</a>	
CNR2	Silent	p.L17L	C	C	rs201490624	11	Filtered Calls	1	24202057	24202057	369	0.504065040650406	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNR2&recr=Open">Click here</a>	
COL1A2	Intron		C	C		11	Filtered Calls	7	94043197	94043197	106	0.245283018867925	NA	NA	NA			115			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	
COL6A1	Silent	p.F618F	C	C	rs372069776	11	Filtered Calls	21	47421198	47421198	205	0.331707317073171	NA	NA	NA			33	C-terminal globular domain.|VWFA 2. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL6A1&recr=Open">Click here</a>	
CREB3L3	Silent	p.V170V	G	G		11	Filtered Calls	19	4159713	4159713	87	0.32183908045977	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CREB3L3&recr=Open">Click here</a>	
CRYBA4	Intron		C	C		11	Filtered Calls	22	27021435	27021435	182	0.236263736263736	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYBA4&recr=Open">Click here</a>	
CSMD3	Silent	p.F138F	G	G		11	Filtered Calls	8	114290921	114290921	105	0.466666666666667	NA	NA	NA		p.F138F(1)|p.F98F(1)	646	CUB 1. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	
CTC-512J12.6	IGR		C	C		11	Filtered Calls	19	44832151	44832151	306	0.457516339869281	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTC-512J12.6&recr=Open">Click here</a>	
CTNNA2	Silent	p.I139I	C	C		11	Filtered Calls	2	80085257	80085257	247	0.11336032388664	NA	NA	NA		p.I139M(2)	78			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNA2&recr=Open">Click here</a>	
CYP2C8	Intron		C	C		11	Filtered Calls	10	96824546	96824546	143	0.426573426573427	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C8&recr=Open">Click here</a>	
CYP39A1	Silent	p.L449L	G	G		11	Filtered Calls	6	46518166	46518166	77	0.233766233766234	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP39A1&recr=Open">Click here</a>	
DAK	Silent	p.R126R	G	G	rs532277913	11	Filtered Calls	11	61106799	61106799	242	0.272727272727273	NA	NA	NA			23	DhaK. {ECO:0000255|PROSITE- ProRule:PRU00814}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAK&recr=Open">Click here</a>	
DALRD3	Intron		G	G		11	Filtered Calls	3	49056009	49056009	23	0.478260869565217	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DALRD3&recr=Open">Click here</a>	
DCAF4	Intron		C	C		11	Filtered Calls	14	73418539	73418539	263	0.505703422053232	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF4&recr=Open">Click here</a>	
DCAF6	Silent	p.D533D	C	C	rs371524406	11	Filtered Calls	1	167992275	167992275	126	0.0396825396825397	NA	NA	NA			36			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF6&recr=Open">Click here</a>	
DCSTAMP	Intron		C	C		11	Filtered Calls	8	105367188	105367188	202	0.202970297029703	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCSTAMP&recr=Open">Click here</a>	
DCT	Intron		G	G		11	Filtered Calls	13	95097989	95097989	14	0.428571428571429	NA	NA	NA			50			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCT&recr=Open">Click here</a>	
DDX4	Intron		C	C		11	Filtered Calls	5	55081182	55081182	130	0.461538461538462	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX4&recr=Open">Click here</a>	
DDX51	Silent	p.I199I	G	G		11	Filtered Calls	12	132627346	132627346	267	0.0224719101123595	NA	NA	NA			10			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX51&recr=Open">Click here</a>	
DDX56	Intron		G	G		11	Filtered Calls	7	44609511	44609511	155	0.561290322580645	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX56&recr=Open">Click here</a>	
DDX60	Intron		G	G		11	Filtered Calls	4	169201753	169201753	118	0.415254237288136	NA	NA	NA			63			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX60&recr=Open">Click here</a>	
DENND1B	Silent	p.L181L	G	G		11	Filtered Calls	1	197614838	197614838	111	0.153153153153153	NA	NA	NA			22	DENN. {ECO:0000255|PROSITE- ProRule:PRU00304}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND1B&recr=Open">Click here</a>	
DGKE	Silent	p.T26T	G	G		11	Filtered Calls	17	54912234	54912234	667	0.0104947526236882	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKE&recr=Open">Click here</a>	
DNAH7	Intron		T	T		11	Filtered Calls	2	196764994	196764994	140	0.15	NA	NA	NA			205			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	
DNAJC11	Intron		G	G		11	Filtered Calls	1	6705089	6705089	541	0.523105360443623	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC11&recr=Open">Click here</a>	
DOK6	Silent	p.S89S	G	G		11	Filtered Calls	18	67266712	67266712	89	0.359550561797753	NA	NA	NA			20	PH.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOK6&recr=Open">Click here</a>	
DSG4	Silent	p.T220T	C	C		11	Filtered Calls	18	28970761	28970761	75	0.52	NA	NA	NA			70	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG4&recr=Open">Click here</a>	
DUOX2	Intron		C	C		11	Filtered Calls	15	45387124	45387124	90	0.2	NA	NA	NA			63			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUOX2&recr=Open">Click here</a>	
DUOX2	Intron		C	C		11	Filtered Calls	15	45387125	45387125	90	0.2	NA	NA	NA			63			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUOX2&recr=Open">Click here</a>	
EFCAB4B	Silent	p.F371F	G	G		11	Filtered Calls	12	3757713	3757713	67	0.313432835820896	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB4B&recr=Open">Click here</a>	
EFCAB6	Silent	p.F20F	A	A		11	Filtered Calls	22	44178139	44178139	206	0.276699029126214	NA	NA	NA			68			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB6&recr=Open">Click here</a>	
EGFLAM	Intron		C	C		11	Filtered Calls	5	38403990	38403990	125	0.352	NA	NA	NA			85			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGFLAM&recr=Open">Click here</a>	
EIF2AK1	Silent	p.S304S	C	C		11	Filtered Calls	7	6080730	6080730	383	0.506527415143603	NA	NA	NA			27	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF2AK1&recr=Open">Click here</a>	
EMR1	Intron		C	C		11	Filtered Calls	19	6935097	6935097	161	0.186335403726708	NA	NA	NA			62			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMR1&recr=Open">Click here</a>	
ENPEP	Silent	p.L744L	C	C		11	Filtered Calls	4	111470690	111470690	205	0.263414634146341	NA	NA	NA			54			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPEP&recr=Open">Click here</a>	
ENPP1	Silent	p.P509P	C	C		11	Filtered Calls	6	132194152	132194152	369	0.306233062330623	NA	NA	NA			46	Phosphodiesterase.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ENPP1&recr=Open">Click here</a>	
EPHA6	Silent	p.Q1106Q	G	G		11	Filtered Calls	3	97467470	97467470	48	0.395833333333333	NA	NA	NA			101			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA6&recr=Open">Click here</a>	
EPHA8	Silent	p.G835G	G	G		11	Filtered Calls	1	22927270	22927270	249	0.542168674698795	NA	NA	NA			61	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA8&recr=Open">Click here</a>	
ERBB2	Intron		C	C		11	Filtered Calls	17	37880968	37880968	84	0.214285714285714	NA	NA	NA			247			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB2&recr=Open">Click here</a>	
ERN1	Silent	p.T944T	G	G		11	Filtered Calls	17	62121450	62121450	244	0.290983606557377	NA	NA	NA			9			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERN1&recr=Open">Click here</a>	
ERP27	Silent	p.F52F	G	G		11	Filtered Calls	12	15090925	15090925	213	0.31924882629108	NA	NA	NA			19	Thioredoxin.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERP27&recr=Open">Click here</a>	
ETV7	Silent	p.L198L	G	G	rs375760531	11	Filtered Calls	6	36339177	36339177	38	0.315789473684211	NA	NA	NA			10			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETV7&recr=Open">Click here</a>	
EXT2	Silent	p.I15I	C	C		11	Filtered Calls	11	44129307	44129307	152	0.296052631578947	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EXT2&recr=Open">Click here</a>	
FAHD2A	Silent	p.V291V	C	C		11	Filtered Calls	2	96078503	96078503	80	0.125	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAHD2A&recr=Open">Click here</a>	
FAIM3	Silent	p.G15G	C	C		11	Filtered Calls	1	207087432	207087432	127	0.582677165354331	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAIM3&recr=Open">Click here</a>	
FAM135B	Intron		G	G		11	Filtered Calls	8	139180298	139180298	116	0.387931034482759	NA	NA	NA			238			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	
FAM181A	Intron		G	G		11	Filtered Calls	14	94391692	94391692	51	0.470588235294118	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM181A&recr=Open">Click here</a>	
FAM19A2	Intron		T	T		11	Filtered Calls	12	62114684	62114684	38	0.131578947368421	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM19A2&recr=Open">Click here</a>	
FAM65C	Silent	p.L521L	G	G		11	Filtered Calls	20	49218695	49218695	53	0.471698113207547	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM65C&recr=Open">Click here</a>	
FANK1	Intron		C	C	rs117261217	11	Filtered Calls	10	127693622	127693622	132	0.0303030303030303	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FANK1&recr=Open">Click here</a>	
FASN	Silent	p.L492L	G	G		11	Filtered Calls	17	80049114	80049114	20	0.15	NA	NA	NA			34	Acyl and malonyl transferases. {ECO:0000250}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FASN&recr=Open">Click here</a>	
FAT4	Silent	p.T1927T	C	C		11	Filtered Calls	4	126329810	126329810	219	0.36986301369863	NA	NA	NA			355	Cadherin 18. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	
FER1L6	Intron		C	C		11	Filtered Calls	8	125131841	125131841	219	0.406392694063927	NA	NA	NA			118			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FER1L6&recr=Open">Click here</a>	
FLG	Silent	p.E3222E	C	C	rs201586762	11	Filtered Calls	1	152277696	152277696	527	0.0986717267552182	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	
FPR2	Silent	p.V242V	C	C		11	Filtered Calls	19	52272637	52272637	106	0.207547169811321	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPR2&recr=Open">Click here</a>	
FPR3	Silent	p.V41V	C	C		11	Filtered Calls	19	52327124	52327124	171	0.245614035087719	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPR3&recr=Open">Click here</a>	
FRAS1	Silent	p.F950F	C	C		11	Filtered Calls	4	79291119	79291119	156	0.442307692307692	NA	NA	NA			103			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRAS1&recr=Open">Click here</a>	
FZD1	Silent	p.R631R	G	G		11	Filtered Calls	7	90896088	90896088	246	0.520325203252033	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FZD1&recr=Open">Click here</a>	
GABRB3	Intron		A	A		11	Filtered Calls	15	26812889	26812889	82	0.268292682926829	NA	NA	NA			68			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRB3&recr=Open">Click here</a>	
GABRB3	Intron		G	G	rs372692704	11	Filtered Calls	15	26828469	26828469	84	0.154761904761905	NA	NA	NA			68			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRB3&recr=Open">Click here</a>	
GADL1	Intron		C	C		11	Filtered Calls	3	30885966	30885966	212	0.367924528301887	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GADL1&recr=Open">Click here</a>	
GCKR	Silent	p.K326K	G	G		11	Filtered Calls	2	27729664	27729664	392	0.119897959183673	NA	NA	NA			29	SIS 2. {ECO:0000255|PROSITE- ProRule:PRU00797}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCKR&recr=Open">Click here</a>	
GGH	Intron		G	G	rs368410745	11	Filtered Calls	8	63936566	63936566	95	0.305263157894737	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GGH&recr=Open">Click here</a>	
GLRA2	Silent	p.P113P	A	A		11	Filtered Calls	X	14599373	14599373	123	0.333333333333333	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLRA2&recr=Open">Click here</a>	
GLUD1	Intron		G	G		11	Filtered Calls	10	88854073	88854073	30	0.3	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLUD1&recr=Open">Click here</a>	
GPX6	Silent	p.L15L	G	G	rs559264173	11	Filtered Calls	6	28483478	28483478	57	0.421052631578947	NA	NA	NA			19			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPX6&recr=Open">Click here</a>	
GRIA2	Silent	p.G719G	G	G		11	Filtered Calls	4	158281161	158281161	91	0.549450549450549	NA	NA	NA			79			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA2&recr=Open">Click here</a>	
GRID1	Silent	p.L338L	C	C		11	Filtered Calls	10	87615885	87615885	147	0.204081632653061	NA	NA	NA			106			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRID1&recr=Open">Click here</a>	
GRIK4	Intron		G	G		11	Filtered Calls	11	120776207	120776207	110	0.309090909090909	NA	NA	NA			69			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK4&recr=Open">Click here</a>	
GSE1	Intron		C	C	rs369861498	11	Filtered Calls	16	85704589	85704589	77	0.324675324675325	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSE1&recr=Open">Click here</a>	
GSTA5	Silent	p.S10S	G	G		11	Filtered Calls	6	52705582	52705582	123	0.447154471544715	NA	NA	NA			15	GST N-terminal.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTA5&recr=Open">Click here</a>	
GUCA1C	Silent	p.K141K	C	C		11	Filtered Calls	3	108634993	108634993	174	0.17816091954023	NA	NA	NA		p.K141N(1)	14	EF-hand 4. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCA1C&recr=Open">Click here</a>	
HECA	Silent	p.S264S	C	C		11	Filtered Calls	6	139487941	139487941	37	0.27027027027027	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECA&recr=Open">Click here</a>	
HELQ	Intron		G	G		11	Filtered Calls	4	84353426	84353426	184	0.25	NA	NA	NA			38			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HELQ&recr=Open">Click here</a>	
HENMT1	Intron		G	G		11	Filtered Calls	1	109191621	109191621	145	0.503448275862069	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HENMT1&recr=Open">Click here</a>	
HEPHL1	Silent	p.P203P	C	C		11	Filtered Calls	11	93796867	93796867	158	0.316455696202532	NA	NA	NA			61	Plastocyanin-like 1.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEPHL1&recr=Open">Click here</a>	
HMCN1	Silent	p.K1136K	G	G		11	Filtered Calls	1	185962344	185962344	298	0.104026845637584	NA	NA	NA			308	Ig-like C2-type 8.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMCN1&recr=Open">Click here</a>	
HOXA4	Silent	p.G169G	C	C		11	Filtered Calls	7	27169846	27169846	19	0.315789473684211	NA	NA	NA			12	Pro-rich (part of the transcriptional activation domain).		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXA4&recr=Open">Click here</a>	
HRH2	Silent	p.L156L	C	C	rs372223883	11	Filtered Calls	5	175110702	175110702	50	0.16	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRH2&recr=Open">Click here</a>	
HTR4	Intron		G	G		11	Filtered Calls	5	147900530	147900530	178	0.471910112359551	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR4&recr=Open">Click here</a>	
IFT172	Intron		G	G		11	Filtered Calls	2	27700192	27700192	108	0.148148148148148	NA	NA	NA			43			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT172&recr=Open">Click here</a>	
IGDCC3	Silent	p.R702R	C	C		11	Filtered Calls	15	65621827	65621827	160	0.36875	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGDCC3&recr=Open">Click here</a>	
IGHD	RNA		C	C		11	Filtered Calls	14	106311999	106311999	89	0.168539325842697	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHD&recr=Open">Click here</a>	
IGLV3-32	RNA		G	G		11	Filtered Calls	22	22937279	22937279	162	0.487654320987654	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLV3-32&recr=Open">Click here</a>	
IGLV5-37	RNA		G	G		11	Filtered Calls	22	22782268	22782268	264	0.462121212121212	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLV5-37&recr=Open">Click here</a>	
IGSF10	Silent	p.K2608K	C	C		11	Filtered Calls	3	151154525	151154525	335	0.447761194029851	NA	NA	NA			116	Ig-like C2-type 12.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF10&recr=Open">Click here</a>	
IL36G	Silent	p.S128S	C	C		11	Filtered Calls	2	113742500	113742500	142	0.542253521126761	NA	NA	NA			14			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL36G&recr=Open">Click here</a>	
IL7R	Silent	p.V253V	C	C	rs201268331	11	Filtered Calls	5	35874603	35874603	250	0.204	NA	NA	NA		p.S252_A254>WN(1)|p.F250_V253>PLGE(1)|p.V253_A254insVLC(1)|p.V253V(1)	126			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL7R&recr=Open">Click here</a>	
INADL	Silent	p.L973L	C	C		11	Filtered Calls	1	62340996	62340996	227	0.475770925110132	NA	NA	NA			103			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INADL&recr=Open">Click here</a>	
IQCB1	Intron		A	A		11	Filtered Calls	3	121514292	121514292	299	0.418060200668896	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCB1&recr=Open">Click here</a>	
IQCB1	Intron		T	T		11	Filtered Calls	3	121514301	121514301	356	0.401685393258427	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCB1&recr=Open">Click here</a>	
IQCD	Silent	p.V155V	G	G		11	Filtered Calls	12	113645507	113645507	170	0.282352941176471	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCD&recr=Open">Click here</a>	
IRGC	Silent	p.F131F	C	C		11	Filtered Calls	19	44223103	44223103	51	0.333333333333333	NA	NA	NA			25	IRG-type G.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRGC&recr=Open">Click here</a>	
ITGA10	Silent	p.S218S	C	C		11	Filtered Calls	1	145530922	145530922	152	0.289473684210526	NA	NA	NA			59	VWFA. {ECO:0000255|PROSITE- ProRule:PRU00219}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA10&recr=Open">Click here</a>	
ITPKB	Silent	p.I813I	G	G		11	Filtered Calls	1	226829634	226829634	231	0.121212121212121	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPKB&recr=Open">Click here</a>	
IWS1	Silent	p.L496L	G	G		11	Filtered Calls	2	128255795	128255795	121	0.43801652892562	NA	NA	NA			28	Glu-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IWS1&recr=Open">Click here</a>	
JAKMIP3	Intron		C	C		11	Filtered Calls	10	133967414	133967414	130	0.515384615384615	NA	NA	NA			31			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAKMIP3&recr=Open">Click here</a>	
KAZN	Intron		C	C		11	Filtered Calls	1	15386664	15386664	139	0.539568345323741	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KAZN&recr=Open">Click here</a>	
KCNJ15	Silent	p.I305I	C	C		11	Filtered Calls	21	39672098	39672098	151	0.28476821192053	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ15&recr=Open">Click here</a>	
KDM5C	Silent	p.I1147I	G	G	rs45442400	11	Filtered Calls	X	53223918	53223918	24	0.708333333333333	NA	NA	NA			82			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM5C&recr=Open">Click here</a>	
KIAA0100	Silent	p.L766L	G	G		11	Filtered Calls	17	26962309	26962309	200	0.315	NA	NA	NA			68			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0100&recr=Open">Click here</a>	
KIAA0319L	Silent	p.L43L	G	G		11	Filtered Calls	1	36019966	36019966	223	0.551569506726457	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0319L&recr=Open">Click here</a>	
KIAA1429	Silent	p.S723S	C	C	rs376309196	11	Filtered Calls	8	95531557	95531557	203	0.0246305418719212	NA	NA	NA			66			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1429&recr=Open">Click here</a>	
KIF13A	Silent	p.S1490S	G	G		11	Filtered Calls	6	17772145	17772145	569	0.321616871704745	NA	NA	NA			64			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF13A&recr=Open">Click here</a>	
KIF26A	Silent	p.P556P	C	C	rs376308267	11	Filtered Calls	14	104639561	104639561	93	0.0860215053763441	NA	NA	NA			21	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF26A&recr=Open">Click here</a>	
KIF2A	Intron		T	T		11	Filtered Calls	5	61668276	61668276	20	0.5	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF2A&recr=Open">Click here</a>	
KIRREL3	Silent	p.I488I	G	G	rs367818668	11	Filtered Calls	11	126306794	126306794	146	0.301369863013699	NA	NA	NA			29	Ig-like C2-type 5.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIRREL3&recr=Open">Click here</a>	
KLHL41	Silent	p.I222I	C	C	rs200835521	11	Filtered Calls	2	170366954	170366954	130	0.484615384615385	NA	NA	NA			NA	BACK.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL41&recr=Open">Click here</a>	
KLHL5	Intron		C	C	rs146536122	11	Filtered Calls	4	39077757	39077757	175	0.205714285714286	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL5&recr=Open">Click here</a>	
KMT2D	Silent	p.K4527K	C	C		11	Filtered Calls	12	49424766	49424766	91	0.285714285714286	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2D&recr=Open">Click here</a>	
KRT12	Silent	p.L433L	C	C		11	Filtered Calls	17	39019392	39019392	119	0.445378151260504	NA	NA	NA			15	Coil 2.|Rod.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT12&recr=Open">Click here</a>	
KRT13	Silent	p.L3L	G	G	rs185787290	11	Filtered Calls	17	39661794	39661794	95	0.347368421052632	NA	NA	NA			33	Head.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT13&recr=Open">Click here</a>	
KRT16	Silent	p.I458I	G	G		11	Filtered Calls	17	39766235	39766235	70	0.0857142857142857	NA	NA	NA			23	Tail.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT16&recr=Open">Click here</a>	
KRT24	Silent	p.E441E	C	C		11	Filtered Calls	17	38855734	38855734	263	0.239543726235741	NA	NA	NA			29	Coil 2.|Rod.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT24&recr=Open">Click here</a>	
L1TD1	Silent	p.G117G	G	G		11	Filtered Calls	1	62672651	62672651	237	0.50210970464135	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+L1TD1&recr=Open">Click here</a>	
LAMA1	Intron		C	C		11	Filtered Calls	18	7008482	7008482	41	0.609756097560976	NA	NA	NA			205			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA1&recr=Open">Click here</a>	
LAMA4	Silent	p.Y332Y	G	G	rs188272639	11	Filtered Calls	6	112506520	112506520	334	0.0149700598802395	NA	NA	NA			100	Domain II and I.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMA4&recr=Open">Click here</a>	
LCP2	Intron		C	C		11	Filtered Calls	5	169693807	169693807	219	0.392694063926941	NA	NA	NA			23			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCP2&recr=Open">Click here</a>	
LGALS12	Intron		C	C		11	Filtered Calls	11	63283709	63283709	72	0.333333333333333	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALS12&recr=Open">Click here</a>	
LGR6	3'UTR		C	C		11	Filtered Calls	1	202288341	202288341	19	0.684210526315789	NA	NA	NA			36			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGR6&recr=Open">Click here</a>	
LILRB4	Intron		C	C		11	Filtered Calls	19	55177840	55177840	109	0.385321100917431	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRB4&recr=Open">Click here</a>	
LRIG3	Silent	p.E570E	C	C		11	Filtered Calls	12	59274454	59274454	91	0.373626373626374	NA	NA	NA			48	Ig-like C2-type 1.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRIG3&recr=Open">Click here</a>	
LRP5	Intron		C	C		11	Filtered Calls	11	68201064	68201064	172	0.273255813953488	NA	NA	NA			63			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP5&recr=Open">Click here</a>	
LRRC49	5'Flank		T	T		11	Filtered Calls	15	71185942	71185942	149	0.302013422818792	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC49&recr=Open">Click here</a>	
LRRC49	5'Flank		G	G		11	Filtered Calls	15	71185943	71185943	148	0.304054054054054	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC49&recr=Open">Click here</a>	
LRRFIP2	Silent	p.S201S	G	G		11	Filtered Calls	3	37125250	37125250	190	0.363157894736842	NA	NA	NA		p.0?(1)	22	DVL3-binding.|Ser-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRFIP2&recr=Open">Click here</a>	
LRTM1	Silent	p.R125R	C	C		11	Filtered Calls	3	54958875	54958875	98	0.448979591836735	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRTM1&recr=Open">Click here</a>	
LSS	5'UTR		T	T		11	Filtered Calls	21	47648660	47648660	32	0.40625	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LSS&recr=Open">Click here</a>	
LST3	Intron		C	C		11	Filtered Calls	12	21033786	21033786	89	0.382022471910112	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LST3&recr=Open">Click here</a>	
MAB21L1	IGR		G	G		11	Filtered Calls	13	36046594	36046594	89	0.48314606741573	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAB21L1&recr=Open">Click here</a>	
MAP4	Silent	p.V1718V	G	G		11	Filtered Calls	3	47950808	47950808	212	0.0235849056603774	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP4&recr=Open">Click here</a>	
MAPK13	Silent	p.P310P	C	C		11	Filtered Calls	6	36106744	36106744	76	0.276315789473684	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAPK13&recr=Open">Click here</a>	
MARK1	Intron		C	C		11	Filtered Calls	1	220789277	220789277	237	0.578059071729958	NA	NA	NA			63			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MARK1&recr=Open">Click here</a>	
MB	Silent	p.K134K	C	C		11	Filtered Calls	22	36003407	36003407	124	0.169354838709677	NA	NA	NA			1			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MB&recr=Open">Click here</a>	
MCC	Silent	p.A705A	G	G		11	Filtered Calls	5	112399779	112399779	114	0.456140350877193	NA	NA	NA			42			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCC&recr=Open">Click here</a>	
MEFV	Silent	p.K241K	C	C		11	Filtered Calls	16	3299002	3299002	134	0.26865671641791	NA	NA	NA			50			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEFV&recr=Open">Click here</a>	
MEGF8	Silent	p.I2459I	C	C		11	Filtered Calls	19	42879967	42879967	61	0.344262295081967	NA	NA	NA			50			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF8&recr=Open">Click here</a>	
MEP1B	Silent	p.I359I	C	C		11	Filtered Calls	18	29790621	29790621	142	0.176056338028169	NA	NA	NA			23	MAM. {ECO:0000255|PROSITE- ProRule:PRU00128}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEP1B&recr=Open">Click here</a>	
MEPE	IGR		C	C		11	Filtered Calls	4	88767218	88767218	205	0.185365853658537	NA	NA	NA			36			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEPE&recr=Open">Click here</a>	
MFHAS1	Silent	p.A782A	G	G		11	Filtered Calls	8	8748223	8748223	94	0.319148936170213	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MFHAS1&recr=Open">Click here</a>	
MGA	Intron		C	C		11	Filtered Calls	15	42021556	42021556	36	0.222222222222222	NA	NA	NA			95			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGA&recr=Open">Click here</a>	
MIR654	RNA		C	C		11	Filtered Calls	14	101506850	101506850	183	0.0983606557377049	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR654&recr=Open">Click here</a>	
MMP12	RNA		C	C		11	Filtered Calls	11	102743641	102743641	48	0.375	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP12&recr=Open">Click here</a>	
MPHOSPH10	Intron		G	G		11	Filtered Calls	2	71367001	71367001	241	0.506224066390041	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPHOSPH10&recr=Open">Click here</a>	
MSH2	Silent	p.S860S	G	G		11	Filtered Calls	2	47707956	47707956	238	0.0210084033613445	NA	NA	NA		p.0?(2)|p.?(2)	112			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSH2&recr=Open">Click here</a>	
MSLN	Intron		C	C	rs375521023	11	Filtered Calls	16	814639	814639	290	0.282758620689655	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSLN&recr=Open">Click here</a>	
MSTO1	Silent	p.E272E	G	G		11	Filtered Calls	1	155582211	155582211	357	0.103641456582633	NA	NA	NA			7			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSTO1&recr=Open">Click here</a>	
MTOR	Silent	p.I2021I	G	G		11	Filtered Calls	1	11187834	11187834	410	0.2	NA	NA	NA			149	Sufficient for interaction with the FKBP1A/rapamycin complex. {ECO:0000250}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTOR&recr=Open">Click here</a>	
MTPN	5'UTR		G	G		11	Filtered Calls	7	135661853	135661853	416	0.0144230769230769	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTPN&recr=Open">Click here</a>	
MUC16	Silent	p.G13297G	C	C		11	Filtered Calls	19	9004927	9004927	24	0.541666666666667	NA	NA	NA			590			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC4	Intron		C	C		11	Filtered Calls	3	195515866	195515866	63	0.238095238095238	NA	NA	NA			51			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC4&recr=Open">Click here</a>	
NEDD1	Silent	p.K484K	G	G		11	Filtered Calls	12	97337495	97337495	101	0.336633663366337	NA	NA	NA			22			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEDD1&recr=Open">Click here</a>	
NEFH	Silent	p.E463E	G	G		11	Filtered Calls	22	29885018	29885018	81	0.185185185185185	NA	NA	NA			30	Tail.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEFH&recr=Open">Click here</a>	
NELFE	Silent	p.P127P	G	G	rs138737372	11	Filtered Calls	6	31922859	31922859	202	0.252475247524752	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NELFE&recr=Open">Click here</a>	
NEO1	Silent	p.Y673Y	C	C		11	Filtered Calls	15	73547097	73547097	267	0.329588014981273	NA	NA	NA			57	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEO1&recr=Open">Click here</a>	
NGEF	Silent	p.I57I	G	G		11	Filtered Calls	2	233839430	233839430	260	0.5	NA	NA	NA			35	Regulatory region; modulates activity toward RHOA, RAC1 and CDC42. {ECO:0000250}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NGEF&recr=Open">Click here</a>	
NID2	Silent	p.S673S	G	G		11	Filtered Calls	14	52507376	52507376	166	0.168674698795181	NA	NA	NA			87	Nidogen G2 beta-barrel. {ECO:0000255|PROSITE-ProRule:PRU00348}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NID2&recr=Open">Click here</a>	
NIPAL1	Silent	p.L68L	T	T		11	Filtered Calls	4	48027242	48027242	287	0.439024390243902	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NIPAL1&recr=Open">Click here</a>	
NKD2	3'UTR		G	G		11	Filtered Calls	5	1038000	1038000	36	0.472222222222222	NA	NA	NA			14			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKD2&recr=Open">Click here</a>	
NLRP10	Silent	p.S521S	C	C	rs369000977	11	Filtered Calls	11	7981596	7981596	117	0.316239316239316	NA	NA	NA			58			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP10&recr=Open">Click here</a>	
NLRP7	Intron		C	C		11	Filtered Calls	19	55449401	55449401	420	0.216666666666667	NA	NA	NA			73			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP7&recr=Open">Click here</a>	
NOL7	Silent	p.A174A	C	C		11	Filtered Calls	6	13620461	13620461	173	0.23121387283237	NA	NA	NA			5			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOL7&recr=Open">Click here</a>	
NPHS1	Silent	p.V157V	C	C		11	Filtered Calls	19	36341918	36341918	64	0.078125	NA	NA	NA			74	Ig-like C2-type 2.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPHS1&recr=Open">Click here</a>	
OBSCN	Silent	p.L4709L	C	C		11	Filtered Calls	1	228492128	228492128	245	0.106122448979592	NA	NA	NA		p.L4334L(1)|p.L4563L(1)|p.L4464L(1)	223	Ig-like 47.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	
OCA2	Silent	p.E693E	C	C		11	Filtered Calls	15	28116393	28116393	70	0.385714285714286	NA	NA	NA			85			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OCA2&recr=Open">Click here</a>	
OLFM4	Silent	p.S56S	C	C		11	Filtered Calls	13	53603139	53603139	160	0.25625	NA	NA	NA			39	Ser-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFM4&recr=Open">Click here</a>	
OLFML1	Silent	p.F60F	C	C		11	Filtered Calls	11	7509408	7509408	111	0.369369369369369	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OLFML1&recr=Open">Click here</a>	
OR14A16	IGR		G	G		11	Filtered Calls	1	247978092	247978092	119	0.630252100840336	NA	NA	NA			45			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14A16&recr=Open">Click here</a>	
OR1M1	Silent	p.I109I	C	C	rs201998994	11	Filtered Calls	19	9204247	9204247	70	0.214285714285714	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1M1&recr=Open">Click here</a>	
OR2W5	RNA		C	C		11	Filtered Calls	1	247654560	247654560	128	0.2109375	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2W5&recr=Open">Click here</a>	
OR4N2	Silent	p.S229S	T	T		11	Filtered Calls	14	20296294	20296294	183	0.0273224043715847	NA	NA	NA		p.S229S(1)	52			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4N2&recr=Open">Click here</a>	
OR4Q3	Silent	p.F178F	C	C		11	Filtered Calls	14	20216120	20216120	135	0.111111111111111	NA	NA	NA			47			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4Q3&recr=Open">Click here</a>	
OR51B2	Silent	p.L18L	C	C		11	Filtered Calls	11	5345474	5345474	56	0.339285714285714	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51B2&recr=Open">Click here</a>	
OR5A1	Silent	p.S165S	C	C		11	Filtered Calls	11	59211136	59211136	417	0.282973621103118	NA	NA	NA			28			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5A1&recr=Open">Click here</a>	
OR6S1	Silent	p.G317G	C	C		11	Filtered Calls	14	21108900	21108900	304	0.440789473684211	NA	NA	NA			23			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6S1&recr=Open">Click here</a>	
OTOP2	Silent	p.S531S	C	C	rs201849243	11	Filtered Calls	17	72929544	72929544	147	0.414965986394558	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP2&recr=Open">Click here</a>	
PCCA	Intron		C	C		11	Filtered Calls	13	101180014	101180014	178	0.179775280898876	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCCA&recr=Open">Click here</a>	
PCDH17	Silent	p.K1022K	A	A		11	Filtered Calls	13	58299014	58299014	143	0.251748251748252	NA	NA	NA			120			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH17&recr=Open">Click here</a>	
PCDHA4	Silent	p.F554F	C	C		11	Filtered Calls	5	140188434	140188434	87	0.413793103448276	NA	NA	NA			78	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA4&recr=Open">Click here</a>	
PCDHB5	Silent	p.A676A	C	C	rs17844425	11	Filtered Calls	5	140517044	140517044	158	0.449367088607595	NA	NA	NA			81			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB5&recr=Open">Click here</a>	
PGM5	Silent	p.L370L	C	C		11	Filtered Calls	9	71080073	71080073	330	0.354545454545455	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PGM5&recr=Open">Click here</a>	
PHLDB1	Intron		C	C		11	Filtered Calls	11	118527383	118527383	105	0.371428571428571	NA	NA	NA			46			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHLDB1&recr=Open">Click here</a>	
PHLDB2	Silent	p.G109G	G	G		11	Filtered Calls	3	111632399	111632399	195	0.271794871794872	NA	NA	NA			55			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHLDB2&recr=Open">Click here</a>	
PHOX2B	Silent	p.T195T	A	A		11	Filtered Calls	4	41748184	41748184	191	0.50261780104712	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHOX2B&recr=Open">Click here</a>	
PIAS4	Silent	p.F348F	C	C		11	Filtered Calls	19	4033480	4033480	20	0.4	NA	NA	NA			17			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIAS4&recr=Open">Click here</a>	
PKHD1L1	Silent	p.P2632P	C	C		11	Filtered Calls	8	110476957	110476957	324	0.234567901234568	NA	NA	NA			263			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	
PKIB	Silent	p.S53S	C	C		11	Filtered Calls	6	123039098	123039098	112	0.232142857142857	NA	NA	NA			4			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKIB&recr=Open">Click here</a>	
PLA2G1B	3'UTR		G	G		11	Filtered Calls	12	120760017	120760017	496	0.320564516129032	NA	NA	NA			7			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G1B&recr=Open">Click here</a>	
PLAU	Silent	p.T410T	G	G		11	Filtered Calls	10	75676257	75676257	44	0.295454545454545	NA	NA	NA			16	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLAU&recr=Open">Click here</a>	
PLCG2	Silent	p.F684F	C	C		11	Filtered Calls	16	81946319	81946319	26	0.423076923076923	NA	NA	NA			58	SH2 2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCG2&recr=Open">Click here</a>	
PLXNA4	Silent	p.L1307L	C	C		11	Filtered Calls	7	131859633	131859633	254	0.496062992125984	NA	NA	NA			45			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXNA4&recr=Open">Click here</a>	
PLXNA4	Silent	p.I1253I	G	G	rs200254516	11	Filtered Calls	7	131864561	131864561	86	0.372093023255814	NA	NA	NA			45			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXNA4&recr=Open">Click here</a>	
POF1B	Silent	p.Q64Q	C	C		11	Filtered Calls	X	84634268	84634268	38	0.605263157894737	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POF1B&recr=Open">Click here</a>	
POLD1	Intron		C	C		11	Filtered Calls	19	50910574	50910574	62	0.419354838709677	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLD1&recr=Open">Click here</a>	
POMGNT1	Silent	p.K518K	C	C		11	Filtered Calls	1	46656442	46656442	205	0.195121951219512	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POMGNT1&recr=Open">Click here</a>	
PPARGC1B	Silent	p.L159L	C	C		11	Filtered Calls	5	149210341	149210341	154	0.409090909090909	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPARGC1B&recr=Open">Click here</a>	
PRUNE2	Silent	p.S379S	G	G		11	Filtered Calls	9	79326053	79326053	67	0.447761194029851	NA	NA	NA			16			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRUNE2&recr=Open">Click here</a>	
PRX	3'UTR		G	G	rs376423497	11	Filtered Calls	19	40901360	40901360	210	0.185714285714286	NA	NA	NA			47			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRX&recr=Open">Click here</a>	
PSD	Silent	p.F406F	G	G		11	Filtered Calls	10	104173861	104173861	188	0.414893617021277	NA	NA	NA			34			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSD&recr=Open">Click here</a>	
PSG2	Intron		C	C		11	Filtered Calls	19	43575845	43575845	468	0.222222222222222	NA	NA	NA			49			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG2&recr=Open">Click here</a>	
PTGIR	Silent	p.A282A	G	G		11	Filtered Calls	19	47124852	47124852	150	0.466666666666667	NA	NA	NA			13			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGIR&recr=Open">Click here</a>	
PTPRS	3'UTR		G	G	rs372163958|rs112899467	11	Filtered Calls	19	5206774	5206774	221	0.475113122171946	NA	NA	NA			61			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRS&recr=Open">Click here</a>	
PUS3	Silent	p.R223R	C	C		11	Filtered Calls	11	125765394	125765394	174	0.258620689655172	NA	NA	NA			10			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PUS3&recr=Open">Click here</a>	
PYCRL	Silent	p.R131R	C	C		11	Filtered Calls	8	144688829	144688829	11	0.454545454545455	NA	NA	NA			5			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PYCRL&recr=Open">Click here</a>	
RALGPS1	Intron		C	C	rs372261269	11	Filtered Calls	9	129931063	129931063	238	0.0210084033613445	NA	NA	NA			19			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RALGPS1&recr=Open">Click here</a>	
RANBP10	Intron		G	G		11	Filtered Calls	16	67761352	67761352	24	0.333333333333333	NA	NA	NA			23			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RANBP10&recr=Open">Click here</a>	
RAPGEF5	Intron		A	A		11	Filtered Calls	7	22259432	22259432	165	0.260606060606061	NA	NA	NA			6			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAPGEF5&recr=Open">Click here</a>	
RASGRF1	Silent	p.S180S	G	G		11	Filtered Calls	15	79341922	79341922	169	0.307692307692308	NA	NA	NA			71			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RASGRF1&recr=Open">Click here</a>	
RBM19	Silent	p.R821R	C	C		11	Filtered Calls	12	114352869	114352869	150	0.353333333333333	NA	NA	NA			55			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM19&recr=Open">Click here</a>	
RBM33	Intron		C	C		11	Filtered Calls	7	155503874	155503874	42	0.523809523809524	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM33&recr=Open">Click here</a>	
RBM33	Intron		C	C		11	Filtered Calls	7	155503876	155503876	42	0.523809523809524	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM33&recr=Open">Click here</a>	
REG1B	Silent	p.L76L	G	G		11	Filtered Calls	2	79313586	79313586	159	0.522012578616352	NA	NA	NA			51	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REG1B&recr=Open">Click here</a>	
RFX6	Silent	p.P175P	C	C		11	Filtered Calls	6	117203550	117203550	128	0.0859375	NA	NA	NA			59			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX6&recr=Open">Click here</a>	
RGS6	Intron		T	T		11	Filtered Calls	14	72924974	72924974	91	0.153846153846154	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS6&recr=Open">Click here</a>	
RNF112	Silent	p.R366R	G	G		11	Filtered Calls	17	19318172	19318172	50	0.36	NA	NA	NA			12	GB1/RHD3-type G.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF112&recr=Open">Click here</a>	
RNF133	Silent	p.L158L	T	T		11	Filtered Calls	7	122338499	122338499	328	0.231707317073171	NA	NA	NA			21	PA.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF133&recr=Open">Click here</a>	
RNF180	Silent	p.S279S	C	C		11	Filtered Calls	5	63509990	63509990	114	0.508771929824561	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF180&recr=Open">Click here</a>	
ROBO2	Silent	p.D1223D	C	C	rs2272164	11	Filtered Calls	3	77671492	77671492	138	0.253623188405797	NA	NA	NA			117			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO2&recr=Open">Click here</a>	
RP11-1007I13.4	RNA		C	C	rs591483	11	Filtered Calls	X	151283871	151283871	54	0.796296296296296	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-1007I13.4&recr=Open">Click here</a>	
RP11-81K2.1	Intron		G	G		11	Filtered Calls	17	47489206	47489206	47	0.361702127659574	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-81K2.1&recr=Open">Click here</a>	
RSPH9	3'UTR		G	G		11	Filtered Calls	6	43638690	43638690	83	0.325301204819277	NA	NA	NA			12			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSPH9&recr=Open">Click here</a>	
RYR2	Silent	p.R3016R	G	G		11	Filtered Calls	1	237850785	237850785	42	0.595238095238095	NA	NA	NA			586			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	
RYR3	Silent	p.L2028L	C	C		11	Filtered Calls	15	33988642	33988642	106	0.424528301886792	NA	NA	NA			311	4 X approximate repeats.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	
SACS	Silent	p.D3925D	G	G		11	Filtered Calls	13	23906240	23906240	253	0.0197628458498024	NA	NA	NA			189			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SACS&recr=Open">Click here</a>	
SAGE1	Intron		C	C		11	Filtered Calls	X	134994954	134994954	35	0.571428571428571	NA	NA	NA			55			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAGE1&recr=Open">Click here</a>	
SALL1	5'Flank		C	C		11	Filtered Calls	16	51176034	51176034	267	0.310861423220974	NA	NA	NA		p.P33P(1)	126			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SALL1&recr=Open">Click here</a>	
SCLT1	Intron		G	G		11	Filtered Calls	4	129867313	129867313	103	0.495145631067961	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCLT1&recr=Open">Click here</a>	
SCN1A	Silent	p.I1622I	G	G		11	Filtered Calls	2	166848835	166848835	173	0.15606936416185	NA	NA	NA			200			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN1A&recr=Open">Click here</a>	
SCN3A	Silent	p.P1149P	G	G		11	Filtered Calls	2	165972032	165972032	209	0.157894736842105	NA	NA	NA			120			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN3A&recr=Open">Click here</a>	
SCN4A	Silent	p.L1081L	G	G		11	Filtered Calls	17	62025327	62025327	93	0.043010752688172	NA	NA	NA			101			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN4A&recr=Open">Click here</a>	
SCN9A	Silent	p.E492E	C	C		11	Filtered Calls	2	167142972	167142972	152	0.493421052631579	NA	NA	NA			108			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN9A&recr=Open">Click here</a>	
SEMA3A	Intron		C	C		11	Filtered Calls	7	83689776	83689776	735	0.00952380952380952	NA	NA	NA			53			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA3A&recr=Open">Click here</a>	
SEMA5B	Intron		G	G		11	Filtered Calls	3	122647833	122647833	93	0.473118279569892	NA	NA	NA			55			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA5B&recr=Open">Click here</a>	
SERPINI2	Intron		G	G		11	Filtered Calls	3	167184833	167184833	95	0.463157894736842	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINI2&recr=Open">Click here</a>	
SGSM1	Silent	p.E27E	G	G		11	Filtered Calls	22	25240881	25240881	134	0.425373134328358	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SGSM1&recr=Open">Click here</a>	
SH3TC1	Intron		G	G		11	Filtered Calls	4	8234194	8234194	108	0.240740740740741	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3TC1&recr=Open">Click here</a>	
SHD	IGR		C	C		11	Filtered Calls	19	4292713	4292713	95	0.357894736842105	NA	NA	NA			14			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHD&recr=Open">Click here</a>	
SIGLEC10	Silent	p.*555*	C	C		11	Filtered Calls	19	51914354	51914354	130	0.2	NA	NA	NA			58			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC10&recr=Open">Click here</a>	
SIGLEC6	Silent	p.R374R	C	C		11	Filtered Calls	19	52031067	52031067	210	0.419047619047619	NA	NA	NA			28			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC6&recr=Open">Click here</a>	
SKI	Intron		G	G	rs566936949	11	Filtered Calls	1	2234719	2234719	722	0.191135734072022	NA	NA	NA			10			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SKI&recr=Open">Click here</a>	
SLC19A2	Silent	p.F42F	G	G		11	Filtered Calls	1	169454879	169454879	25	0.2	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC19A2&recr=Open">Click here</a>	
SLC24A1	Silent	p.F477F	C	C		11	Filtered Calls	15	65917849	65917849	195	0.292307692307692	NA	NA	NA			23			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC24A1&recr=Open">Click here</a>	
SLC35F3	Intron		G	G		11	Filtered Calls	1	234452485	234452485	141	0.106382978723404	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC35F3&recr=Open">Click here</a>	
SLC45A3	Silent	p.F275F	G	G	rs143103785	11	Filtered Calls	1	205632094	205632094	108	0.574074074074074	NA	NA	NA			21			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC45A3&recr=Open">Click here</a>	
SLC4A8	Silent	p.V576V	C	C		11	Filtered Calls	12	51865140	51865140	226	0.283185840707965	NA	NA	NA			55			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A8&recr=Open">Click here</a>	
SLC6A1	Silent	p.F53F	C	C		11	Filtered Calls	3	11059056	11059056	156	0.282051282051282	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A1&recr=Open">Click here</a>	
SLC8A1	Silent	p.V59V	C	C		11	Filtered Calls	2	40657244	40657244	138	0.478260869565217	NA	NA	NA			100			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC8A1&recr=Open">Click here</a>	
SLC9C2	Silent	p.P856P	G	G	rs372976537	11	Filtered Calls	1	173493180	173493180	202	0.51980198019802	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9C2&recr=Open">Click here</a>	
SMG5	Intron		G	G		11	Filtered Calls	1	156228957	156228957	60	0.566666666666667	NA	NA	NA			48			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG5&recr=Open">Click here</a>	
SMG5	Intron		T	T		11	Filtered Calls	1	156228958	156228958	58	0.568965517241379	NA	NA	NA			48			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG5&recr=Open">Click here</a>	
SOBP	Silent	p.T38T	C	C		11	Filtered Calls	6	107824878	107824878	186	0.241935483870968	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOBP&recr=Open">Click here</a>	
SPACA1	Silent	p.R73R	G	G		11	Filtered Calls	6	88763674	88763674	107	0.411214953271028	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPACA1&recr=Open">Click here</a>	
SPDEF	Silent	p.K274K	C	C		11	Filtered Calls	6	34507034	34507034	250	0.288	NA	NA	NA			15			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPDEF&recr=Open">Click here</a>	
SPTA1	Intron		G	G		11	Filtered Calls	1	158583664	158583664	110	0.1	NA	NA	NA			307			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
SPTBN5	Silent	p.L3116L	G	G		11	Filtered Calls	15	42147497	42147497	63	0.301587301587302	NA	NA	NA			62			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTBN5&recr=Open">Click here</a>	
SRGAP3	Intron		G	G		11	Filtered Calls	3	9055228	9055228	36	0.472222222222222	NA	NA	NA			54			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRGAP3&recr=Open">Click here</a>	
SSH3	Silent	p.S196S	C	C		11	Filtered Calls	11	67074893	67074893	61	0.278688524590164	NA	NA	NA			19			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSH3&recr=Open">Click here</a>	
SSPO	RNA		G	G		11	Filtered Calls	7	149492428	149492428	75	0.506666666666667	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSPO&recr=Open">Click here</a>	
STAB2	Intron		C	C		11	Filtered Calls	12	104096921	104096921	91	0.373626373626374	NA	NA	NA			174			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	
STK33	Silent	p.I218I	G	G		11	Filtered Calls	11	8478931	8478931	121	0.322314049586777	NA	NA	NA			23	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK33&recr=Open">Click here</a>	
STXBP1	Intron		G	G		11	Filtered Calls	9	130422392	130422392	116	0.0517241379310345	NA	NA	NA			23			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP1&recr=Open">Click here</a>	
SWAP70	Intron		C	C		11	Filtered Calls	11	9715684	9715684	218	0.284403669724771	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SWAP70&recr=Open">Click here</a>	
SYCE3	IGR		C	C		11	Filtered Calls	22	50988123	50988123	183	0.387978142076503	NA	NA	NA			2			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYCE3&recr=Open">Click here</a>	
SYNE1	Silent	p.L7462L	C	C		11	Filtered Calls	6	152534855	152534855	176	0.318181818181818	NA	NA	NA			524			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	
SYNJ2	Silent	p.R1156R	G	G	rs374673064	11	Filtered Calls	6	158510882	158510882	70	0.285714285714286	NA	NA	NA			46			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNJ2&recr=Open">Click here</a>	
TAS2R39	Silent	p.F142F	C	C		11	Filtered Calls	7	142880937	142880937	406	0.490147783251232	NA	NA	NA		p.F142L(1)	20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R39&recr=Open">Click here</a>	
TAS2R41	Silent	p.V109V	G	G		11	Filtered Calls	7	143175292	143175292	189	0.301587301587302	NA	NA	NA			18			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R41&recr=Open">Click here</a>	
TBC1D5	Silent	p.S652S	G	G		11	Filtered Calls	3	17208397	17208397	120	0.225	NA	NA	NA			36			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D5&recr=Open">Click here</a>	
TCHH	Silent	p.F74F	G	G		11	Filtered Calls	1	152085471	152085471	146	0.089041095890411	NA	NA	NA			105	EF-hand 2. {ECO:0000255|PROSITE- ProRule:PRU00448}.|S-100-like.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCHH&recr=Open">Click here</a>	
TECPR2	Intron		C	C		11	Filtered Calls	14	102964065	102964065	34	0.117647058823529	NA	NA	NA			50			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TECPR2&recr=Open">Click here</a>	
TEKT4	Silent	p.T343T	C	C		11	Filtered Calls	2	95541425	95541425	90	0.477777777777778	NA	NA	NA			28			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEKT4&recr=Open">Click here</a>	
TEX13B	5'UTR		C	C		11	Filtered Calls	X	107225361	107225361	29	0.655172413793103	NA	NA	NA			28			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX13B&recr=Open">Click here</a>	
THNSL2	Intron		C	C		11	Filtered Calls	2	88482300	88482300	148	0.587837837837838	NA	NA	NA			27			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THNSL2&recr=Open">Click here</a>	
THSD1	Silent	p.F267F	G	G		11	Filtered Calls	13	52971587	52971587	96	0.34375	NA	NA	NA			30			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD1&recr=Open">Click here</a>	
TIMM50	5'Flank		G	G	rs574246446	11	Filtered Calls	19	39971447	39971447	17	0.705882352941177	NA	NA	NA			14			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIMM50&recr=Open">Click here</a>	
TIMM50	5'Flank		G	G		11	Filtered Calls	19	39971448	39971448	18	0.666666666666667	NA	NA	NA			14			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TIMM50&recr=Open">Click here</a>	
TJP2	Silent	p.A998A	C	C		11	Filtered Calls	9	71865953	71865953	349	0.329512893982808	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TJP2&recr=Open">Click here</a>	
TK2	Silent	p.I53I	G	G	rs137854432	11	Filtered Calls	16	66575854	66575854	208	0.197115384615385	NA	NA	NA			4			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TK2&recr=Open">Click here</a>	
TLL1	Silent	p.A181A	C	C		11	Filtered Calls	4	166916241	166916241	244	0.213114754098361	NA	NA	NA		p.A181A(1)	77	Metalloprotease. {ECO:0000250}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL1&recr=Open">Click here</a>	
TLN2	Intron		G	G	rs375139763	11	Filtered Calls	15	63030405	63030405	132	0.310606060606061	NA	NA	NA			99			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLN2&recr=Open">Click here</a>	
TMCC3	Silent	p.F61F	G	G		11	Filtered Calls	12	94976210	94976210	231	0.350649350649351	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMCC3&recr=Open">Click here</a>	
TMEM150C	Silent	p.S7S	G	G	rs202058879	11	Filtered Calls	4	83425790	83425790	63	0.0952380952380952	NA	NA	NA			1			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM150C&recr=Open">Click here</a>	
TMEM39B	Silent	p.T245T	G	G	rs201087426	11	Filtered Calls	1	32557420	32557420	92	0.0434782608695652	NA	NA	NA			11			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM39B&recr=Open">Click here</a>	
TMPRSS3	Silent	p.A115A	G	G	rs142577467	11	Filtered Calls	21	43808613	43808613	211	0.260663507109005	NA	NA	NA			13	SRCR. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS3&recr=Open">Click here</a>	
TNKS1BP1	Silent	p.L1481L	G	G		11	Filtered Calls	11	57070175	57070175	27	0.37037037037037	NA	NA	NA			64	Acidic.|Tankyrase-binding.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNKS1BP1&recr=Open">Click here</a>	
TOMM40	Silent	p.A202A	C	C	rs201592778	11	Filtered Calls	19	45397286	45397286	162	0.388888888888889	NA	NA	NA			5			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOMM40&recr=Open">Click here</a>	
TONSL	Silent	p.L166L	G	G		11	Filtered Calls	8	145668140	145668140	254	0.232283464566929	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TONSL&recr=Open">Click here</a>	
TP53BP1	Silent	p.H695H	G	G		11	Filtered Calls	15	43748721	43748721	305	0.324590163934426	NA	NA	NA			72			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP53BP1&recr=Open">Click here</a>	
TPH2	Silent	p.Q416Q	G	G		11	Filtered Calls	12	72425121	72425121	266	0.296992481203008	NA	NA	NA			41			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPH2&recr=Open">Click here</a>	
TRAF3IP3	5'UTR		G	G		11	Filtered Calls	1	209946322	209946322	178	0.134831460674157	NA	NA	NA			32			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAF3IP3&recr=Open">Click here</a>	
TRBV7-6	RNA		C	C		11	Filtered Calls	7	142139486	142139486	234	0.282051282051282	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV7-6&recr=Open">Click here</a>	
TRIM6-TRIM34	Silent	p.F826F	C	C		11	Filtered Calls	11	5664888	5664888	457	0.269146608315098	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM6-TRIM34&recr=Open">Click here</a>	
TRPM3	Silent	p.R1275R	C	C		11	Filtered Calls	9	73152168	73152168	214	0.313084112149533	NA	NA	NA			95			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM3&recr=Open">Click here</a>	
TSPEAR	Silent	p.G313G	C	C		11	Filtered Calls	21	45947181	45947181	120	0.316666666666667	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPEAR&recr=Open">Click here</a>	
TSPYL5	Silent	p.N370N	G	G		11	Filtered Calls	8	98288963	98288963	524	0.0133587786259542	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPYL5&recr=Open">Click here</a>	
TSSC4	IGR		G	G		11	Filtered Calls	11	2427989	2427989	93	0.376344086021505	NA	NA	NA			8			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSSC4&recr=Open">Click here</a>	
TTC26	Intron		C	C		11	Filtered Calls	7	138874062	138874062	460	0.447826086956522	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC26&recr=Open">Click here</a>	
U2SURP	Silent	p.P933P	C	C		11	Filtered Calls	3	142773809	142773809	33	0.272727272727273	NA	NA	NA			31	Arg/Ser-rich.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+U2SURP&recr=Open">Click here</a>	
UBE2V2	5'UTR		C	C		11	Filtered Calls	8	48955660	48955660	387	0.0155038759689922	NA	NA	NA			3			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBE2V2&recr=Open">Click here</a>	
UBQLNL	Silent	p.P461P	G	G		11	Filtered Calls	11	5536289	5536289	300	0.256666666666667	NA	NA	NA			33			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBQLNL&recr=Open">Click here</a>	
UNC13A	Silent	p.T551T	C	C		11	Filtered Calls	19	17759403	17759403	176	0.198863636363636	NA	NA	NA			61			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC13A&recr=Open">Click here</a>	
UNC45B	Silent	p.R761R	G	G		11	Filtered Calls	17	33507599	33507599	117	0.282051282051282	NA	NA	NA			59			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC45B&recr=Open">Click here</a>	
USP10	Silent	p.P438P	G	G		11	Filtered Calls	16	84792998	84792998	124	0.314516129032258	NA	NA	NA			17	USP.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP10&recr=Open">Click here</a>	
USP43	Silent	p.L651L	C	C		11	Filtered Calls	17	9604957	9604957	17	0.588235294117647	NA	NA	NA			26	USP.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP43&recr=Open">Click here</a>	
USP50	Intron		G	G		11	Filtered Calls	15	50831057	50831057	109	0.311926605504587	NA	NA	NA			13			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP50&recr=Open">Click here</a>	
Unknown	IGR		-	-		11	Filtered Calls	2	106986182	106986183	137	0.145985401459854	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
Unknown	IGR		C	C		11	Filtered Calls	5	64511299	64511299	59	0.559322033898305	NA	NA	NA			NA			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+Unknown&recr=Open">Click here</a>	
VAT1L	Intron		G	G		11	Filtered Calls	16	78011485	78011485	55	0.272727272727273	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VAT1L&recr=Open">Click here</a>	
VCAN	Intron		C	C		11	Filtered Calls	5	82834607	82834607	246	0.430894308943089	NA	NA	NA			190			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCAN&recr=Open">Click here</a>	
VGLL2	Silent	p.F18F	C	C		11	Filtered Calls	6	117586980	117586980	91	0.373626373626374	NA	NA	NA			5			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VGLL2&recr=Open">Click here</a>	
VWF	Silent	p.L1214L	C	C		11	Filtered Calls	12	6131098	6131098	312	0.333333333333333	NA	NA	NA			129			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	
WDR70	Intron		C	C		11	Filtered Calls	5	37721208	37721208	252	0.297619047619048	NA	NA	NA			37			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR70&recr=Open">Click here</a>	
WRN	Silent	p.L893L	A	A		11	Filtered Calls	8	30982086	30982086	154	0.37012987012987	NA	NA	NA			60	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WRN&recr=Open">Click here</a>	
WSCD1	Silent	p.R37R	G	G		11	Filtered Calls	17	5984089	5984089	23	0.739130434782609	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WSCD1&recr=Open">Click here</a>	
WWC1	Intron		G	G		11	Filtered Calls	5	167868842	167868842	26	0.615384615384615	NA	NA	NA			43			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WWC1&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168102914	168102914	118	0.432203389830508	NA	NA	NA			315			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XPO7	Intron		C	C		11	Filtered Calls	8	21839235	21839235	153	0.0326797385620915	NA	NA	NA			36			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XPO7&recr=Open">Click here</a>	
YTHDF2	Silent	p.F99F	C	C		11	Filtered Calls	1	29069079	29069079	244	0.221311475409836	NA	NA	NA			20	Localization to mRNA processing bodies (P-bodies).		MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YTHDF2&recr=Open">Click here</a>	
ZAN	RNA		C	C		11	Filtered Calls	7	100367594	100367594	14	0.214285714285714	NA	NA	NA			139			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZAN&recr=Open">Click here</a>	
ZBTB47	Silent	p.Y618Y	C	C		11	Filtered Calls	3	42705405	42705405	47	0.340425531914894	NA	NA	NA			13			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB47&recr=Open">Click here</a>	
ZBTB7B	5'UTR		G	G		11	Filtered Calls	1	154987131	154987131	98	0.0816326530612245	NA	NA	NA			29			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB7B&recr=Open">Click here</a>	
ZDHHC24	Intron		G	G	rs144950495	11	Filtered Calls	11	66307210	66307210	43	0.372093023255814	NA	NA	NA			7			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC24&recr=Open">Click here</a>	
ZNF133	Silent	p.I481I	C	C		11	Filtered Calls	20	18296941	18296941	106	0.320754716981132	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF133&recr=Open">Click here</a>	
ZNF227	IGR		C	C		11	Filtered Calls	19	44739685	44739685	107	0.214953271028037	NA	NA	NA			24			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF227&recr=Open">Click here</a>	
ZNF419	Silent	p.L387L	C	C		11	Filtered Calls	19	58005083	58005083	309	0.233009708737864	NA	NA	NA			26			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF419&recr=Open">Click here</a>	
ZNF536	Silent	p.P1217P	C	C	rs201688634	11	Filtered Calls	19	31040177	31040177	96	0.229166666666667	NA	NA	NA			182			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF536&recr=Open">Click here</a>	
ZNF572	Silent	p.R180R	A	A		11	Filtered Calls	8	125989048	125989048	209	0.239234449760766	NA	NA	NA			31			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF572&recr=Open">Click here</a>	
ZNF608	Silent	p.H1467H	G	G		11	Filtered Calls	5	123976994	123976994	248	0.0201612903225806	NA	NA	NA			46			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF608&recr=Open">Click here</a>	
ZNF609	Silent	p.P492P	C	C	rs138233871	11	Filtered Calls	15	64966529	64966529	100	0.34	NA	NA	NA			39			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF609&recr=Open">Click here</a>	
ZNF652	Silent	p.V321V	G	G		11	Filtered Calls	17	47390145	47390145	296	0.273648648648649	NA	NA	NA			20			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF652&recr=Open">Click here</a>	
ZNF7	IGR		C	C		11	Filtered Calls	8	146067980	146067980	152	0.309210526315789	NA	NA	NA			25			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF7&recr=Open">Click here</a>	
ZPLD1	Silent	p.T384T	G	G	rs140794333	11	Filtered Calls	3	102196366	102196366	510	0.401960784313726	NA	NA	NA			35			MEL-IPI_Pat100-Tumor-SM-53U2D	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZPLD1&recr=Open">Click here</a>	
